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ABSTRACT 
 
The Role of Neutrophil Recruitment in the Pathogenesis of Salmonella enterica 
Serotype Typhimurium-Induced Enteritis in Calves. (December 2007) 
Jairo Eduardo dos Santos Nunes, D.V.M., Universidade Federal de Uberlândia; 
M.Sc., Universidade Federal de Minas Gerais 
Chair of Advisory Committee: L. Garry Adams 
 
 
The role of neutrophils in the pathogenesis of Salmonella 
typhimurium-induced ruminant and human enteritis and diarrhea remains 
incompletely understood. To address this question, the in vivo bovine ligated ileal 
loop model of non-typhoidal salmonellosis was used in calves with the naturally-
occurring Bovine Leukocyte Adhesion Deficiency (BLAD) mutation whose 
neutrophils are unable to extravasate and infiltrate the extravascular matrix. Data 
obtained from BLAD calves were compared to those from genetically normal 
calves negative for the BLAD mutation. Morphologic studies showed that the 
absence of significant tissue influx of neutrophils in intestine infected by S. 
typhimurium resulted in less tissue damage, reduced luminal fluid accumulation, 
and increased bacterial invasion compared to regular calves. Study of gene 
expression profile of cytokines by quantitative Real-Time PCR (qRTPCR) 
revealed that the massive tissue influx of neutrophils during acute infection is 
mainly driven by the CXC chemokine GRO-α especially in the last stages of 
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acute infection and to a lesser extent, IL-8. In contrast, the pro-inflammatory 
cytokines IL-1β and TNF-α were not significantly correlated with the presence or 
absence of tissue neutrophils.  
The precise in situ localization of gene expression of these major 
cytokines and chemokines was investigated by qRTCPR from specific groups of 
intestinal cells captured by Laser Capture Microdissection in S. typhimurium-
infected ileal loops from BLAD animals. Our data confirmed that gene expression 
of IL-8, GRO-α, and IL-1β was predominantly localized to enterocytes of crypts 
with less expression in enterocytes of villi tips and cells that form the domed villi 
were not an important source of TNF-α gene expression. Microarray technology 
was used to determine the global transcriptional profile of bovine intestinal loops 
inoculated with S. typhimurium. The host samples were hybridized on a 13K 
bovine-specific oligoarray and microarray data was analyzed using a suite of 
gene expression analysis and modeling tools. Analysis of our data revealed that 
the tissue influx of neutrophils in ileal loops greatly influenced the host gene 
expression. Major differences in gene expression in relevant fields of Salmonella 
research including inflammation and immune response, Toll-like receptor 
signaling, cytokine profiles, apoptosis, and intracellular defense against infection 
are discussed. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
Salmonellosis 
 
 
Salmonellosis is one of the most common food-borne bacterial 
diseases in the world (47, 59, 180) and a major cause of enteric disease in both 
humans and animals (48). In humans, an estimated 1.4 million new cases and 
500 deaths occur annually in the United States alone (121). Approximately 
40,000 cases of enteric human Salmonellosis are reported to the Center of 
Disease Control (CDC) every year (87). Recent data published by the CDC 
reporting the prevalence of food-born disease outbreaks from 1998-2002 
identified a bacterial etiology in 18% of all outbreaks, with Salmonella accounting 
for almost half of these (63). Despite the fact that Salmonellosis is a recognizable 
notifiable disease, the number of reported cases is believed to be highly 
underestimated since CDC estimates the occurrence of approximately 38 
unreported cases for every case reported to national surveillance throughout the 
United States (87).  
This dissertation follows the style of Infection and Immunity. 
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Worldwide, non-typhoidal Salmonellosis causes 1.3 billion new 
cases each year resulting in 3 million deaths (143). Humans are often infected by 
consumption of animal products (76) and cattle constitute an import reservoir for 
human infections (214). Approximately 95% of human Salmonella infections are 
food-borne, accounting for 30% of all deaths caused by food-borne infections in 
the United States (121). In cattle, particularly in calves, S. typhimurium is a major 
cause of calf morbidity and mortality (174, 214). Medical and productivity costs 
as a result of Salmonella infections in humans and cattle result in annual losses 
in the range of 0.6 to 3.5 billion dollars (121). 
Currently, more than 2,400 Salmonella serotypes have been 
identified (22). According to the most recent classification adopted by the CDC, 
all serotypes belong to two species only, namely S. enterica, which is 
represented by more than 2,400 serotypes, and S. bongori represented by 20 
serotypes (22). S. enterica is further subdivided in six subspecies which are 
numbered I, II, IIa, IIb, IV, and VI, and named enterica, salamae, arizonae, 
diarizonae, houtenae, and indica respectively (22). Warm-blooded animals are 
infected with serotypes that belong to subspecies I (22). In this dissertation, the 
simplified denotation S. typhimurium will be used to replace Salmonella enterica 
subsp. enterica ser. Typhimurium, with the same rule being applied to other 
serotypes within the subspecies enterica hereafter.  
Salmonella enterica encompasses a diverse range of bacteria that 
cause a spectrum of diseases in many hosts (15). Despite the large numbers of 
serovars identified to date, clinical disease in humans and animals results from 
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infection by relatively few serovars, which can be divided in three major groups 
based upon host prevalence (192). The first group is formed by host-specific 
serovars that typically cause clinical disease in a limited number of 
phylogenetically related species. Common serovars in this group include Typhi 
and Gallinarum, which result almost exclusively in systemic disease in humans 
and fowls respectively. The second group consists of host-restricted strains that 
primarily result in clinical disease in one or two closely related host species but 
may also occasionally cause disease in other hosts. Typical serovars in this 
group include Dublin and Cholerasuis, which primarily cause systemic disease in 
ruminants and pigs respectively, yet may potentially infect other animal species 
and humans. The third group is composed of ubiquitous serovars that commonly 
induce gastroenteritis in a broad range of unrelated and related host species 
such as Typhimurium and Enteritidis. 
Salmonellosis in humans has two principal clinical manifestations 
known as typhoidal and non-typhoidal diseases (21). The most prevalent 
typhoidal Salmonella serovars, Typhi and Paratyphi, cause severe systemic 
illness that can lead to death (21). A recent study revised the global burden of 
typhoid fever and concluded that an estimated 20 million cases and 200,000 
deaths occurs worldwide each year as a result of typhoidal Salmonellosis, with 
south-central Asia and south-east Asia showing the highest incidence of the 
disease (34). Non-typhoidal Salmonellosis is typically characterized by a self-
limiting gastroenteritis, although serious complications, including systemic 
disease and death may occur in immunocompromised people (86, 148). 
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According to a recent worldwide study reported to the World Health Organization 
(WHO) global Salmonella survey, serovar Enteritidis is the most common human 
isolate of non-typhoidal Salmonellosis followed by Typhimurium and Newport 
(180). The same study identified serovar Typhimurium as the most frequent non-
human isolate followed by Heidelberg and Enteritidis. 
Salmonellosis in cattle occurs world widely and has been 
associated primarily with serovars Typhimurium, Dublin, and Newport to a lesser 
extent (24, 154). The peak of disease incidence in calves infected with S. 
typhimurium is at three weeks of age, whereas spread of S. dublin in infected 
calves is slower resulting in disease peak at 4-5 weeks of age (217). Clinical 
signs in young calves vary, but regardless of the serovar, the enteric form of the 
disease typically predominates, with diarrhea being the most important clinical 
manifestation of infection (216). Infection of calves with the host-adapted S. 
dublin; however, may cause a septicemic systemic disease affecting a variety of 
organs in the absence of enteric involvement, causing most commonly 
meningoencephalitis, polyarthritis, osteomyelitis, and pneumonia (154). In 
addition, infection with S. dublin in pregnant cows and heifers may cause 
abortion (84).  
Clinical signs are typically divided into three forms based on the 
duration of infection and final outcome, named peracute, acute, and chronic (90). 
Peracute infections are often manifested as death in the absence of clinical signs 
and a clinical course of less than two days (200). Acute infections are typically 
manifested as a diarrheal disease and the mortality rate depends on the 
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presence or absence of treatment, ranging between 10 to 60% (200). The 
chronic form of the disease is usually less severe, more common in older calves, 
and may or not be associated with diarrhea (200).  
Pathologic findings as a result of S. typhimurium infection in calves 
are limited to the intestine (187). Post-mortem examination in early stages of 
infection reveals congestion and fluid distention of the jejunum and ileum 
followed by formation of a fibrinous pseudomembrane within the lumen, typically 
attached to the surface of Peyers patches in the ileal mucosa (215). In addition, 
mesenteric lymph nodes are often enlarged (215). Histologically, villi blunting 
precedes massive tissue influx of neutrophils, followed by transmigration of 
neutrophils into crypts and lumen, Peyers Patch necrosis, and ultimately 
mucosal necrosis (164). 
 
 
Pathogenesis of S. typhimurium-induced Enteritis 
 
 
Although the complete mechanism of Salmonella-induced diarrhea 
is still unclear, the pathogenesis of S. typhimurium-induced enteritis has been 
extensively investigated and partially characterized by various studies using the 
bovine model of Salmonella-induced diarrhea (161, 164). The disease in cattle is 
a useful model for Salmonella-induced enteritis and diarrhea in humans, because 
the clinical manifestations of the disease are similar in both species (165). In both 
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humans and cattle, infection with S. typhimurium remains localized to the 
intestine and manifests as an acute neutrophilic enteritis and diarrhea (161). In 
contrast, mice infected with S. typhimurium develop a systemic disease with 
characteristic absence of diarrhea, similarly to human typhoid fever caused by 
the serotypes Typhi, Paratyphi A, B, and C (10, 91, 221). 
The ligated intestinal loop model in calves have been used in most 
studies on the pathogenesis of S. typhimurium-induced enteritis using the bovine 
model (159, 163, 164, 191, 221-223). The model allows molecular and 
morphologic characterization of the host and agent responses to infection in the 
same animal under several distinct experimental conditions, such as distinct 
bacterial backgrounds and different times post-infection. It has been used to 
study the pathogenesis of S. typhimurium-induced enteritis is several species 
besides the bovine, including pigs (20, 123, 124), sheep (193), mice (147), and 
rabbits (45, 67, 202). 
Shortly after infection in calves, as early as 5 minutes (54), S. 
typhimurium colonize the intestine, preferentially the ileum, where a higher 
density of gut-associated lymphoid tissue represented by the ileal Peyers 
patches is present (161, 164). Once believed to invade only M-cells, it has now 
become well established based on studies using the bovine and swine models, 
that S. typhimurium can infect a variety of intestinal cells, including goblet cells, 
enterocytes of absorptive and domed villi, as well as macrophages and 
neutrophils in the lamina propria (54, 123, 124, 164). Intestinal cellular invasion is 
followed by villi blunting and activation of pro-inflammatory cytokines and CXC 
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chemokines (IL-8, GROα, GROγ, and GCP-1) that promote massive tissue influx 
of neutrophils peaking at 4 hours post-infection (164, 221, 222). Extravasated 
neutrophils transmigrate through the epithelial barrier formed by enterocytes, 
infiltrating into crypts and the lumen (164). Severe neutrophilic enteritis is 
followed by detachment of surface enterocytes with disruption of epithelial 
basement membrane, fibrin and fluid exudation into the lumen resulting in 
pseudomembrane formation, and ultimately necrosis of the mucosa and diarrhea 
(164).  
Ultrastructural studies have demonstrated that Salmonella, when in 
contact with the epithelial barrier, induce cytoskeleton changes in enterocytes 
resulting in apical membrane ruffling formation, a process culminating in bacterial 
engulfment (54, 78, 164). In addition, bacterial attachment is often associated 
with loss of microvilli (164). Studies in the swine model suggest that invading S. 
typhimurium has a specific affinity to sites of cell extrusion (124). After invasion, 
Salmonella reside in acidified membrane-bound compartments called 
Salmonella-containing vacuoles (SCV) (205). Recent evidence based on S. 
typhimurium infection in dendritic cells suggest that wild type virulent strains are 
contained in spacious phagosomes and are organized in groups of multiple 
organisms, whereas mutant strains with attenuated virulence remains within tight 
phagosomes that closely follow the contour of the bacteria and occur mainly as 
single profiles (101). 
The major virulent genes required by S. enterica to cause infections 
in susceptible hosts are carried on discrete regions of the chromosome called 
  
8
Salmonella pathogenicity islands (128). Salmonella pathogenicity islands (SPI) 
are essential for host cell invasion and intracellular pathogenesis (80). Although 
14 SPIs has been identified to date, SPI-1 and SPI-2 are considered central to 
the virulence of S. enterica in mammals (128), because they both encode a 
dedicated protein secretion system, termed type III secretion system (TTSS), 
which determine the ability of S. typhimurium successfully invade and colonize 
the intestine (57, 75, 89). During infection, the activated TTSS resembles a 
needle-like structure that enable Salmonella to translocate SPI-encoded effector 
proteins directly into the host cell cytoplasm, where the proteins manipulate the 
host cell signaling (56-58).  The TTSS has a complex structure composed of 
several proteins that interact to form a base, inner rod, and a needle allowing 
delivery of effector proteins into host cells (58). The TTSS has been described in 
variety of pathogenic and symbiotic bacteria, as well as plants, nematodes, and 
insects (58). In S. typhimurium, the base is composed of three proteins: InvG that 
makes up the outer rings plus PrgH and PrgJ, which supposedly form the rest of 
the structure (114). The putative inner rod protein and needle proteins are PrgJ 
and PrgI respectively (58, 105). In addition, a regulatory protein named InvJ is 
required for appropriate assembly of the complex but is not part of the final 
structure (58, 105).  
Two major types of TTSS are important during the pathogenesis of 
Salmonella infections, the TTSS-1 and TTSS-2 (58). TTSS-1 is encoded by SPI-
1 and is essential for S. typhimurium invasion (56) and enteritis in the bovine 
model (187). Other functions being attributed to TTSS-1 with a role in Salmonella 
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pathogenesis include reorganization of host cell structure and invasion of 
fibroblasts and epithelial cells (81), transmigration of polymorphonuclear 
granulocytes (PMNs) across epithelial cell layers (107), and cell death (94). In 
contrast, the SPI-2-encoded type III secretion system, termed TTSS-2, plays a 
essential role in facilitating the replication of intracellular bacteria within 
membrane-bound SCV (205) and is required for Salmonella replication within 
host cells and establishment of systemic infection in the murine typhoid model 
(53).  
The TTSS-1 is required for invasion of the bovine intestine (207), 
triggering the production of CXC chemokines, neutrophil recruitment (187, 221, 
222), fluid accumulation, and diarrhea (187, 206, 222). In the bovine model, 
strains carrying mutations in effector proteins translocated by TTSS-1 such as 
SipA, SopA, SopB, SopD or SopE2 had markedly reduced enteropathogenicity 
resulting in attenuated fluid accumulation (223). Since mutations impairing 
components of the TTSS-1 complex result in similarly attenuated strains during 
oral infections in calves, it is hypothesized that S. typhimurium TTSS-1 functions 
mainly to translocate six effector proteins; SipA, SopA, SopB, SopD, SopE, and 
SopE2, into host cells during bovine enteritis (149). 
The molecular pathogenesis of intestinal epithelium invasion is 
beginning to be characterized. Studies using non-polarized human epithelial cell 
lines concluded that the genes SopB, SopE, and SopE2 are required for invasion 
(224), whereas SopD and SopA does not appear to be required (150). A series of 
elegant studies have demonstrated that SopE, SopE2, and SopB, upon delivery 
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by the TTSS-1, activate specific Rho Family GTPases (Rac1, RhoG, and Cdc42) 
that mediate invasion-related cellular responses such as actin remodeling, 
macropinocytosis, and nuclear responses (144). Accordingly, SopE and SopE2 
are guanine nucleotide exchange factors that directly activate Rac1 and Cdc42. 
Rac1 is required for S. typhimurium entry and activation of Cdc42 results in 
nuclear responses within host cells, such as production of IL-8. It was also 
demonstrated in these studies that SopB, an inositol phosphatase, indirectly 
activates RhoG by directly stimulating SH3-containing guanine nucleotide 
exchange factor, an exchange factor for RhoG. This indirect action of SopB over 
RhoG plays a central role in actin cytoskeleton remodeling during infection 
accounting for the SopD-dependent invasion phenotype. SipA has also been 
shown to play a role in invasion by directly interacting with the structural 
components of the actin filaments inducing cytoskeleton rearrangements (225, 
226). In addition, there is also evidence that SopA and SopD contribute to 
invasion in non-polarized cells, but similar results were not observed in polarized 
colon carcinoma cell lines (150). 
In calves, transepithelial migration of S. typhimurium after invasion 
occurs rapidly as opposed to evidence of persistence and replication within SCV 
as reported in in vitro studies (149). The bacteria are first seen in the apical 
border and rapidly transit to a basolateral location at or before one hour post-
infection, followed by invasion of lamina propria at one to four hours post-
infection (161, 164). The molecular mechanisms governing CXC chemokine 
production and neutrophilic inflammation are yet poorly characterized. Strains 
  
11
carrying mutations of sipB, invH or combined mutations of sipA, sopA, sopB, 
sopD, and sopE2 induce markedly reduced inflammatory responses and fluid 
secretion in calves (206, 223). Evidence of the TTSS-1 translocated effector 
proteins SipA, SopE, and SopE2 contributing for S. typhimurium-induce enteritis 
is supported by studies employing the streptomycin-pretreated-mouse model (14, 
76). This model has been proved to be useful to investigate the factors that 
contribute to trigger Salmonella-induced enteritis in vivo (21). Mutation of sptP, 
avrA, sspH1 or alrP had no effect on enteritis and fluid secretion in calves 
suggesting that not all TTSS-1 protein-encoded genes are required for 
inflammation and diarrhea (221). Some in vitro studies using human intestinal 
epithelial cell lines found conflicting results since they demonstrate that mutants 
defective for translocation of TTSS-1 effector proteins induce the same levels of 
CXC chemokines production in wild type and mutant strains (65, 66, 220). In 
human epithelial cell lines, immune recognition of bacterial flagellin appears to be 
the dominant mechanism for CXC chemokine production (65, 66, 88, 183, 220).  
Flagellin, a principal component of bacterial flagella, is part of 
pathogen-associated molecular patterns (PAMPs) which are expressed on 
several infectious agents, but not on the host (79). S. typhimurium flagellin is 
recognized by Toll-like receptor 5 (TLR5) (79), which is expressed in the 
basolateral area of intestinal epithelial cells (65). The restricted localization of the 
TLR5 in intestinal cells prevents its activation by PAMPs expressed in 
commensal intestinal bacteria (149). Despite the evidence showing the 
importance of flagellin triggering chemokine production, in vivo studies in calves 
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have found that S. typhimurium with inactivated TTSS-1 results in much stronger 
reduction of neutrophilic infiltration compared to a strain with inactivated flagellin 
(167), indicating that flagellin-mediated TLR5 activation is not the only 
mechanism contributing to enteritis (149). Similar to activation of the 
inflammatory response, the molecular mechanisms driving fluid secretion and 
diarrhea during Salmonella-induced enteritis is incompletely characterized. Fluid 
secretion in epithelial cells appear to be mediated by sopB through activation of 
chloride secretion (142), but there is paucity of current evidence supporting this 
finding. 
 
 
Bovine Leukocyte Adhesion Deficiency 
 
 
Bovine leukocyte adhesion deficiency (BLAD) is a lethal autosomal 
recessive congenital disease of Holstein cattle characterized by recurrent 
bacterial infections, delayed wound healing, stunted growth, and the 
characteristic marked and persistent neutrophilia (130, 132, 135). Affected calves 
have recurrent bacterial infections that fail to respond to conventional treatment 
(184) and usually die before reaching sexual maturity (68, 100, 182). The most 
commonly observed clinical manifestations of the disease in calves are gingivitis, 
alveolar periostitis, diarrhea, bronchopneumonia, peripheral lymphadenopathy, 
and chronic dermatitis (68, 130). Recurrent necrotic and indolent infections of 
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soft tissues affecting especially the oral mucous membrane and intestinal tract is 
considered the hallmark of BLAD (6, 14, 133, 135). 
The condition was first recognized in a Holstein heifer in 1983 and 
called granulocytopathy, because a neutrophil dysfunction was suspected to be 
the cause (74). In 1987, several cases of bovine granulocytopathy syndrome 
characterized by defective inflammatory responses and impaired neutrophil 
functions were reported in Japan (138, 139, 182). In 1990, the cause of the 
condition was determined to be a lack of β2 integrin molecules expressed on the 
leukocytes, and it was renamed Bovine Leukocyte Adhesion Deficiency (99). 
Ever since, several cases of BLAD have been reported in Holsteins in several 
countries of Europe, Australia, USA, and Japan (132).  
The causative genetic defect of BLAD is a single point mutation 
(adenine to guanine) at the position 383 of the of β2 integrin subunit CD18, which 
results in an aspartic acid to glycine substitution at amino acid 128 (D128G) (62, 
132, 171). This mutation occurs within an extracellular region highly conserved 
among integrin β subunits, near 26 aminoacids identical in normal bovine, human 
and murine CD18 (171). A second silent single point mutation, cytosine to 
thymine, has also been identified between the normal and the BLAD allele at 
position 775 of the CD18 gene (171). Distinction between normal, carrier, and 
affected animals is normally determined though restriction analysis of PCR 
products amplified from position 383 of the CD18 gene (127, 181, 184). The 
carrier frequency of BLAD among Holstein cattle in the US had once reached 
15% among bulls and 6% among cows, making this condition one of the most 
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common genetic diseases known in animal agriculture (171). Continuous 
screening of young bulls before entering artificial insemination stations has 
significantly reduced the incident of BLAD (146). BLAD is considered a good 
animal model for the remarkably similar condition in humans termed Leukocyte 
Adhesion Deficiency (LAD) (71) and for efficient control of genetic disorders 
mediated by a single recessive mode of inheritance (132). 
The common beta subunit of β2 integrins, CD18, associates with 
four different alpha chains (CD11) to give rise to four distinct integrins: 
CD11a/CD18 (LFA-1), CD11b/CD18 (Mac-1), CD11c/CD18 (CR4), and 
CD11d/CD18 (70). LFA-1 is expressed in all leukocytes, particularly T and B 
lymphocytes, as well as many leukocyte-derived cells such as macrophages (11, 
132). Neutrophils express LFA-1, Mac-1, and CR4; however, Mac-1 is expressed 
at significant higher levels in activated neutrophils (55). Mac-1 and CR4 are also 
expressed in neutrophils, monocytes/macrophages, and natural killer cells (180). 
While CR4 is the most prominent integrin expressed in activated tissue 
macrophages (11), CD11d/CD18,  is abundant in peripheral blood CD8+ 
lymphocytes as well as in some tissue-compartmentalized macrophages (196). 
Since association between subunits CD11 and CD18 within 
activated leukocytes is critical for expression of the β2 integrin heterodimer on 
the cell surface (176), the defective CD18 subunit of BLAD calves result in 
deficient expression of all four classes of β2 integrins on leukocytes of affected 
calves (4, 33, 71). Binding of β2 integrins on the neutrophil surface to intercellular 
adhesion molecule 1 (ICAM-1) on vascular endothelium is required for neutrophil 
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emigration into sites of inflammation, therefore BLAD calves have impaired 
extravasation of neutrophils into sites of inflammation (135). A notable exception 
occurs in lungs of calves experimentally infected with the bacteria Mannheimia 
haemolytica, the etiologic agent of Bovine Pneumonic Pasteurellosis. 
Accordingly, studies using BLAD calves have demonstrated that β2 integrin-
ICAM-1 adherence mediates neutrophil extravasation and infiltration into the 
bronchi during Pneumonic Pasteurellosis, but it is not required for neutrophil 
infiltration into the bronchioles and alveoli (2, 3).  
In addition to deficient extravasation, BLAD calf neutrophils have 
marked functional abnormalities including severely decreased adherence, 
chemotactic movements, phagocytosis, luminol-dependent chemiluminescent 
response, and O(2-)- producing activities (135). Adherence and chemotactic 
responses of mononuclear phagocytes from cattle with BLAD are also markedly 
reduced (137). Although delayed and impaired, antibody production was found to 
take place in immunized BLAD calves, indicating lymphocyte reactivity (131). 
Immune stimulation of BLAD calves revealed severely delayed and defective 
antigen-specific immune responses (131). Neutrophils from BLAD also have 
significantly decreased expression of L-selectin compared to control calves 
(134). Regarding BLAD carriers, β2 integrin expression on neutrophils from 
heterozygous animals is 56 to 99% compared to neutrophils from normal cows 
(33); however, leukocytes from BLAD carriers had no detectable functional 
differences when compared with normal controls (172). 
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The Role of Neutrophils in S. typhimurium-induced Enteritis 
 
 
Despite the fact that massive neutrophilic influx is the 
histopathologic hallmark of S. typhimurium-induced enteritis in humans and 
calves (190), the role of neutrophils in the pathogenesis of non-typhoidal 
Salmonellosis remains to be better characterized. In addition, the mechanisms 
leading to the massive neutrophil recruitment is uncertain to date. One proposed 
mechanism is that S. typhimurium triggers the massive neutrophil influx into 
tissues by activating gene expression of pro-inflammatory cytokines in intestinal 
cells through the action of translocated effector proteins (190). A second 
hypothesis suggests that S. typhimurium has a more passive role by proposing 
that activation of neutrophilic inflammation occurs as a result of binding of 
Salmonella PAMPs to pathogen recognition receptors in cells of the lamina 
propria (190). 
Studies using the ligated ileal loop model in calves infected with S. 
typhimurium suggest that the massive tissue influx of neutrophils lead to loss of 
epithelial integrity resulting in effusion of a protein-rich exudates into the intestinal 
lumen, thereby contributing to diarrhea (222). Corroborative evidence that 
neutrophil influx contribute to diarrhea is supported by studies in rabbit ligated 
ileal loops showing that treatment with nitrogen mustard, an inhibitor of neutrophil 
influx, inhibited fluid secretion induced by Salmonella (202). Alternatively, 
neutrophils may contribute to diarrhea by stimulating chloride secretion in 
intestinal epithelial cells (112). Accordingly, activated neutrophils in the lumen 
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release a neutrophil-derived secretagogue identified as 5'-AMP, which induces 
electrogenic chloride secretion in the intestinal epithelia resulting in secretory 
diarrhea (112). Diarrhea has also been associated with the inositol phosphatase 
activity of SopB, which may directly trigger chloride secretion through changes in 
phosphatidylinositol signaling (142). 
While much evidence points to the harmful effects of neutrophil 
influx to the host during non-typhoidal Salmonellosis, this response is likely 
important to reduce infection and prevent systemic spread (149). Infection of 
rabbit ligated ileal loops with Shigella flexneri demonstrated that neutrophil influx 
is essential for preventing bacterial dissemination within the lamina propria (157). 
Regardless of these findings, neutrophils are in general not considered effective 
in the control of intracellular pathogens despite being an important component of 
innate immunity (26). Investigation of the role of neutrophils in the murine model 
of typhoidal Salmonellosis suggests that neutrophils are unable to control 
systemic spread and replication of S. typhimurium in organs with large bacterial 
loads, whereas the rapid neutrophil influx observed in the intestine of non-
typhoidal models of Salmonellosis prevents the spread of the pathogen (26).  
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Objectives 
 
 
Based on the current literature available on the pathogenesis of S. 
typhimurium-induced enteritis, it is clear that the contribution of neutrophils 
remains incompletely understood. The overall goal of this work is to better 
characterize the role of neutrophil recruitment in the bovine model of non-
typhoidal Salmonellosis. The BLAD calf is used here as a model for absence or 
markedly reduced neutrophil influx into sites of infection, allowing determination 
of molecular and morphologic changes induced independently of neutrophilic 
inflammation. Chapter II of this dissertation evaluates the in vivo host response to 
S. typhimurium at the morphologic and immunologic levels with emphasis in the 
kinetics of changes induced by infection in the absence of neutrophils as well as 
determination of gene expression of major pro-inflammatory cytokines during 
infection. Chapter III identifies the in vivo contribution of specific cell types 
targeted by S. typhimurium during intestinal infection by demonstrating the 
influence of neutrophils over the gene expression of pro-inflammatory cytokines. 
Chapter IV identifies the most relevant in vivo differentially expressed genes and 
their dynamic temporal relationship during S. typhimurium infection in the 
absence of significant neutrophilic enteritis. 
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CHAPTER II 
 
 
MORPHOLOGIC AND CYTOKINE PROFILE CHARACTERIZATION OF 
Salmonella typhimurium INFECTION IN CALVES WITH BOVINE 
LEUKOCYTE ADHESION DEFICIENCY 
 
 
Introduction 
 
 
Salmonella enterica serovar Typhimurium (hereafter S. 
typhimurium) is the most frequent non-human isolate and among the three most 
common human isolate of non-typhoidal salmonellosis (180). The non-typhoidal 
form of salmonellosis is characterized by a self-limiting enterocolitis with diarrhea 
in the absence of systemic disease (31). This form results in between 200 million 
and 1.3 billion cases including 3 million deaths each year worldwide (210). 
Moreover, S. typhimurium is a major cause of calf morbidity and mortality 
resulting in significant economic losses (121). The 2004 Salmonella report 
published by the Center of Disease Control (CDC) reported cattle as the most 
commonly identified source for Salmonella spp., including S. typhimurium, which 
was the most frequent serovar isolated from humans in that year. According to a 
CDC analysis on the impact of foodborne illnesses, non-typhoidal salmonellosis 
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accounted for 25.6% of hospitalizations and 30.6% of deaths due to known 
foodborne pathogens in the United States (121). The disease is markedly similar 
in both humans and cattle, making the calf an excellent model to study the non-
typhoidal form of salmonellosis (165, 221). 
The morphologic changes and profile of selected chemokines, as 
well as pro- and anti-inflammatory cytokines have been characterized in calves 
by using the ileal loop model of S. typhimurium-induced enteritis (161, 164). 
Accordingly, infection of ileal Peyers patches by S. typhimurium results in severe 
tissue influx of neutrophils, which is thought to play a significant role in the 
pathogenesis of enteritis and diarrhea induced by S. typhimurium infections (161, 
164). The massive tissue influx of neutrophils was associated with increased 
expression the CXC chemokines IL-8, GROα, GROγ, and GCP-2, the pro-
inflammatory cytokine IL-1β, and anti-inflammatory cytokines IL-1Ra and IL-4 
(164). In a similar study using the same model, the CXC chemokine GROα was 
considered the most important stimulus for tissue influx of neutrophils (221).  In 
vivo studies using the ligated intestinal loop model in rabbits also found that 
Salmonella-induced fluid secretion and diarrhea is inhibited by depletion of 
neutrophilic pool by nitrogen mustard (202). 
Hypothetically, the tissue influx of neutrophils induces loss of 
epithelial integrity and effusion of a protein rich exudate into the intestinal lumen 
contributing to diarrhea (222). Alternatively, neutrophils may contribute to 
diarrhea by directly stimulating chloride secretion in intestinal epithelial cells. 
Mice experimentally infected with S. typhimurium typically develop the typhoid 
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form of salmonellosis characterized by systemic disease with a mild monocytic 
enteritis, minimal intestinal infiltration of neutrophils, and mild epithelial damage 
(221). The classic lack of diarrhea observed in these animals corroborates with 
evidence that neutrophil influx plays a major role in fluid secretion. In addition, 
infection by S. typhimurium in mice elicit intestinal gene expression of CC 
chemokines, which are mainly chemoattractant to mononuclear cells, rather than 
neutrophilic chemoattractants (CXC chemokines) (221), indicating that these 
striking differences in host responses to infection are a reflection of the distinctive 
cytokine profile in infected calves and mice.  
Salmonella effector proteins encoded by genes sipA (sspA), sopA, 
sopB (sigD), sopD, and sopE2 are components of the invasion-associated type 
III secretion system (TTSS-1), which is required for eliciting neutrophil influx and 
fluid accumulation in bovine ligated ileal loops (60, 96, 163, 213, 223). Calves 
infected with a S. typhimurium carrying simultaneous mutations in all TTSS-1-
associated genes (sipAsopABDE2 mutant or ZA21) had markedly attenuated 
tissue influx of neutrophils, mild epithelial damage, and severely reduced fluid 
secretion (221, 222). The presence of these genes is also required for CXC 
chemokine gene expression in bovine but not in murine intestinal tissue (221). In 
addition, orally infected calves infected by Salmonella strains carrying mutations 
in structural components of the TTSS-1 (prgH) have attenuated pathogenicity 
similar to the mutant strain ZA21 (187, 188), highlighting the importance of this 
secretion system in the pathogenesis of S. typhimurium-induced enteritis. 
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To develop a better understanding of the host response to non-
typhoidal salmonellosis, with particular emphasis in the role played by 
neutrophils, we employed the ligated ileal loop model in calves with bovine 
leukocyte adhesion deficiency (BLAD). BLAD is an autosomal recessive 
congenital condition of Holstein cattle characterized by an impaired extravasation 
of neutrophils into sites of inflammation (135). The condition is caused by a 
single point mutation (adenine to guanine) at position 383 of the common β2 
integrin subunit CD18, resulting in defective expression of β2 integrin in the 
surface of leukocytes (62, 132, 171). Since binding of β2 integrin expressed in 
the surface of activated neutrophils to intracellular adhesion molecule-1 (ICAM-1) 
expressed in activated endothelial cells is required for extravasation of 
neutrophils into sites of inflammation, the defective expression of β2 integrin in 
BLAD neutrophils render these animals incapable of mounting an adequate 
neutrophilic response against bacterial infections (62, 135). Here, we used BLAD 
calves as a neutrophil knockout model to describe the histologic and 
ultrastructural changes, and the profile of gene expression of major chemokines 
and pro-inflammatory cytokines in bovine Peyers patches infected with S. 
typhimurium.  
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Materials and Methods 
 
 
Bacterial strains and growth conditions 
 
 
Strains of S. typhimurium used in this study included the Wild Type 
strain IR715 (ATCC 14028 wild type nal) (178) and the mutant strain ZA21 
(∆sipAsopABDE2 - ATCC 14028 nal) (223). All strains were grown in Luria-
Bertani (LB) medium with nalidixic acid antibiotic (50 mg/liter) under agitation 
(250 rpm) overnight at 37oC; 50 µl of the culture was inoculated into 5 ml of fresh 
LB medium and subculture for additional 4 hours before inoculation. 
 
 
Animals, surgical procedure, and sampling 
 
 
A total of four BLAD Holstein calves, 1 to 5 weeks of age, 
represented by both genders, weighting approximately 35 to 55 Kg were used in 
these experiments. All calves were homozygous for the BLAD defect (CD18 -/-) 
as determined by a PCR-based DNA test combined with restriction enzyme 
analysis (99, 171). Embryo transfer technology (168) was used to generate 3 
BLAD calves present in this study. The other calf as well as all BLAD embryos 
were donated by the USDA/ARS National Animal Disease Center (NADC)  
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Ames, IA. The calves were kept clinically healthy before the experiments at the 
Large Animal Hospital of the College of Veterinary Medicine, Texas A&M 
University, College Station, TX, and negative for Salmonella spp. as determined 
by fecal culture using enrichment in tetrathionate broth (Difco, Detroit, MI). 
Calves were fed antibiotic-free milk replacer twice a day, water ad libitum, and 
fasted 24 hours prior to experimental surgeries. The ligated ileal loop surgical 
procedure was employed as previously described (164, 166). Briefly, anesthesia 
was induced with propofol (Abbot Laboratories, Chigaco, IL) followed by 
placement of endotracheal tube and maintenance with isofluorane (Abbot 
Laboratories, Chigaco, IL) for the duration of the experiment. A laparotomy was 
performed, the ileum and jejunum were exposed and 16-20 loops, 5 to 8 cm long, 
were ligated in the ileum and distal jejunum, intercalated with 1-2 cm loops. The 
loops were injected with 3 ml of either sterile LB broth (control loops) or LB 
containing approximately 0.75 x 109 colony-forming units (cfu) of the S. 
typhimurium strains previously described. Loops were replaced into the 
abdominal cavity and excised at 1, 4, 8, and 12 hours post-infection (HPI). 
Samples for bacteriologic culture, histopathology, transmission and scanning 
electron microscopy, and quantitative real time PCR (qRT-PCR) were collected. 
Data collected from bacteriology, fluid secretion, gene expression of cytokines 
and chemokines were compared to four control, age-matched, male Holstein 
calves negative for the BLAD defect (CD18 +/+) submitted to similar 
experimental protocols. 
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Fluid secretion, bacteriologic culture, and histopathology 
 
 
Excised loops were opened and the amount of accumulated fluid 
was measured in metric units. Two 6 mm biopsy punches were taken from the 
intestinal mucosa and submucosa along the anti-mesenteric side, including the 
Peyers patches, washed 3 times in 5 ml of phosphate buffer saline (PBS), 
homogenized in 900 µl of PBS, serially diluted, and plated onto nalidixic acid (50 
mg/liter) containing LB plates (223) for cfu enumeration. Intestinal samples were 
fixed in neutral 10% buffered formalin, processed according to routine 
procedures for paraffin embedding, sectioned at 4-5 µm, and stained with 
hematoxylin and eosin (H&E). 
 
 
Scanning and transmission electron microscopy 
 
 
Several small fragments of the intestinal samples were fixed 
overnight at 4oC in a solution composed of 5% glutaraldehyde and 4% 
paraformaldehyde in 0.1M sodium cacodylate buffer and processed as previously 
described (164). Briefly, after fixation, samples were washed 3 times with 0.1M 
sodium cacodylate buffer and post fixed for 2 hours at 4oC in 1% osmium 
tetroxide in 0.1M sodium cacodylate buffer. For transmission electron 
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microscopy, the samples were stained overnight at 4oC in a saturated uranyl 
acetate solution, dehydrated in graduated series of ethanol solutions and 
propylene oxide, and embedded in Epon-Araldite. Sections 0.5 µm thick were 
stained with toluidine blue and examined under light microscopy for selection of 
microscopic fields that included villi, lamina propria with crypts, muscularis 
mucosa, and submucosa. Blocks were trimmed to produce thin sections (60-90 
nm), mounted onto copper grids, stained with uranyl acetate and lead citrate, and 
examined with a Zeiss 10C transmission electron microscope. For scanning 
electron microscopy, samples were dehydrated, dried, coated with approximately 
500 Å thin layer of AuPd and examined with a JEOL JSM-6400 scanning electron 
microscope at an accelerating voltage of 15 kV. 
 
 
Real time polymerase chain reaction (qRTPCR) 
 
 
As a source of host RNA, six to eight 6 mm biopsy punches were 
taken from the intestinal samples including Peyers patches. Punches were 
immediately cleaned to remove debris, minced into small pieces with a sterile 
scalpel or razor blade, immersed in 500 µl of 4oC TRI-reagent® (Ambion, Foster 
City, CA) and further homogenized using a tissue grinder. The RNA was 
extracted the same day according to TRI-reagent manufacturer instructions, the 
pellet was resuspended in nuclease-free water (Ambion, Foster City, CA), and 
  
27
contaminant DNA was removed by RNase-free DNase I treatment (Ambion, 
Foster City, CA) according to manufacturers instructions. Samples were stored 
at -80oC until used. The resultant DNA-free RNA was quantified using a 
NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, 
DE) and assessment of RNA quality was determined using an Agilent 2100 
Bioanalyser (Agilent Technologies, Santa Clara, CA).  
Selected RNA samples of adequate quality from each condition 
was used to determine the gene expression levels of IL-8, GRO-α, IL-1β, and 
TNF-α by qRTPCR as previously described (221). Briefly, 2 µg of RNA was 
reverse transcribed at 48 oC for 30 min with random hexamer primers and 
Multiscribe Reverse Transcriptase (Applied biosystems, Foster City, CA). The 
resultant cDNA at concentration of 40 ηg per sample was mixed with 4 SmartMix 
beads per sample (Cepheid, Sunnyvale, CA), SYBRGreen-I 0.2x (Invitrogen 
Corporation, Carlsbad, CA) and 500 nM of each primer set (Table 1). The 
qRTPCR reaction was performed using a Smart Cycler II (Cepheid, Sunnyvale, 
CA). The quantitative gene expression of each cytokine and chemokine was 
normalized to the internal control glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). The normalized levels of gene expression in infected tissues were 
calculated relative to uninfected control tissues as previously described (221). 
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Statistical analysis 
 
 
The effects of S. typhimurium wild type (WT) and sipAsopABDE2 
mutant (MT) infection on intestinal invasion, fluid secretion, and gene expression 
of cytokines and chemokines were analyzed by calculation of geometric means 
and standard deviation, followed by the use of a Students t test to determine 
differences with statistical significance (p < 0.05). 
 
 
Table 1- Primer sequences used in qRTPCR to study the gene expression of S. 
typhimurium infected bovine intestine. 
Target Primer sequencea Amplicon size (bp) 
GAPDH TTCTGGCAAAGTGGACATCGT 
GCCTTGACTGTGCCGTTGA 
114 
 
GRO-α CACTGCGACCAAACCGAAGT 
GTATCAAGAAGCTCGTTCCAT 
153 
IL-8 TGCTTTTTTGTTTTCGGTTTTTG 
AACAGGCACTCGGGAATCCT 
71 
IL-1β CCAGCCTGGCAAAAACCAT 
CCGGAAATTGGTTCCACAGT 
201 
TNF-α GTTCCTCACCCACACCATCAG 
GGTAGTCCGGCAGGTTGATC 
283 
 
aSequences for bovine genes were obtained from GenBank. Top row represents 
forward primers and bottom row shows reverse primers. 
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Results 
 
 
Morphologic findings 
 
 
Histologic evaluation of intestinal sections of BLAD Calves (CD18 -
/-) calves was limited to the distal jejunal and ileal mucosa and submucosa. 
Morphologic changes in the muscular layers were disregarded to avoid inclusion 
of artifacts resultant from surgical manipulation and the use of electrocautery for 
loop excision. All sections from uninfected control loops were histologically within 
normal limits. Histologic lesions in BLAD calves were not observed in tissues 
infected by any of the strains used (WT and MT) at 1 HPI. At this time point, the 
absorptive villi retained normal morphology showing no evidence of blunting 
(Figs. 1A, B, C), and inflammatory infiltrates were not observed. The first 
histologic changes were detected at 4 HPI, characterized by mild blunting of the 
absorptive villi in WT-infected tissues from three animals (Fig. 2A). In addition to 
blunting, mild exudation of fibrin into the lumen admixed with karyorrhectic 
cellular debris (pseudomembrane formation) and infrequent detachment of 
enterocytes from the basal membrane was occasionally observed in WT-infected 
samples (Fig. 2B). Histologic lesions were not detected in any of the MT-infected 
tissues in this time point, as well as in the WT-infected loop from one animal. As 
with 1 HPI, inflammation was not significant in any tissues examined regardless 
the strain. 
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Figure 1: Normal histologic appearance of absorptive villi in uninfected control (A), WT- (B), and 
MT-infected samples. 1 hour post-infection. BLAD calf (CD18 -/-). H&E.  
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Figure 2: Mild villi blunting (A) and detachment of enterocytes at the tip of absorptive villi with 
fibrinous pseudomembrane formation (B) in WT-infected samples. 4 hours post-infection. Marked 
blunting, shortening, and fusion of villi in WT-infected samples (C). 8 hours post-infection. BLAD 
calf (CD18 -/-). H&E.  
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Marked histologic lesions began to be detected at 8 HPI in BLAD 
calves. In general, while both WT- and MT-infected loops had similar lesions, the 
severity of changes was markedly reduced in tissues infected by the MT strain, 
particularly in 2 animals, which exhibited mild changes when compared to 
uninfected control samples. In addition, differences in severity of lesions for both 
WT- and MT-infected tissues were evident with two calves having marked lesions 
whereas the other two calves generally had similar but milder lesions. Villi were 
often markedly blunt, shortened, and fused (Fig. 2C). Enterocytes along tips of 
absorptive and domed villi were occasionally detached from the basement 
membrane and replaced or disrupted by karyorrhectic and pyknotic cellular 
debris indicating necrosis. Necrosis appeared first at the tips and progressed 
towards the basolateral surface of villi (Fig. 3A). Necrotic debris was also 
occasionally evident scattered in the lamina propria on both absorptive and 
domed villi (Fig. 3B). Inflammation was generally mild and limited to a few 
perivascular neutrophils in the submucosa. Neutrophils were rarely observed in 
the lamina propria. Occasional crypts contained a few desquamated enterocytes 
and necrotic debris. Crypts filled with viable and degenerate neutrophils (crypt 
abscesses) were not observed in any of the samples.  
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Figure 3: Necrosis of villi tips and basolateral surface (A), scattered necrosis in throughout the villi 
lamina propria (B), and vascular necrosis with extravasation of neutrophils and erythrocytes into 
the submucosa (C) in WT-infected samples. 8 hours post-infection. BLAD calf (CD18 -/-). H&E.  
 
  
34
A few mucosal and several submucosal small blood vessels 
(arterioles, capillaries, and venules) contained fibrin thrombi and were often 
packed with circulating neutrophils. Occasionally, these vessels had walls 
disrupted by fibrin and necrotic debris (vasculitis with fibrinoid necrosis) allowing 
neutrophil extravasation (Fig. 3C). The submucosa was expanded by edema, 
fibrin, and occasional hemorrhage. A fibrinous pseudomembrane, often meager, 
admixed with a few desquamated enterocytes, covered the lumen in some 
animals.  
No histologic lesions were observed in the submucosal lymphoid 
tissue (Peyers patches) in any of the samples at any time point (Figs 4A and 
4B). At 12 HPI, the mucosa was markedly collapsed and reduced in thickness 
resulting often in complete atrophy and fusion of villi (Fig. 4C). Vascular lesions 
similarly to the ones observed at 8 HPI were more frequently seen in the 
submucosa. These vessels were often surrounded by large numbers of 
neutrophils, abundant fibrin, edema, and occasional hemorrhage. As with 8 HPI, 
necrotic enterocytes tended to concentrate along the entire surface of villi in WT-
infected samples contrasting the preferential occurrence at tips of villi in MT-
infected samples. Other lesions observed were similar to the ones described 
above at 8 HPI for both WT- and MT-infected loops.  
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Figure 4: Normal appearance of Peyers patches in uninfected control (A) and WT-infected 
sample (B). 8 hours post-infection. Severe villi atrophy in WT-infected sample (C). 12 hours post-
infection. BLAD calf (CD18 -/-). H&E. 
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Ultrastructurally, evidence of WT S. typhimurium invasion was 
observed in epithelial cells at 1 HPI in most sections evaluated. In contrast, 
invading or internalized MT bacteria were infrequently seen at any time point. 
Invasion of epithelial cells was often associated with disruption of microvilli and 
apical membrane ruffle formation (Fig. 4, A-B). Invasive bacteria commonly 
targeted both enterocytes at tips of villi and M-cells in the domed villi of the 
follicle associated epithelium overlying Peyers patches, while goblet cells were 
rarely infected. Invading organisms were located in membrane-bound vacuoles 
of two types, either spacious vacuoles containing multiple organisms or within 
tight phagosomes that closely followed the contour of the bacteria. Epithelial cells 
containing bacteria often displayed variable degrees of degenerative changes 
including cell swelling, rarefaction of cytoplasm, mitochondrial swelling with 
disruption of cristae, and dilation of endoplasmatic reticulum (Fig. 4C). 
Occasional WT and rare MT-bacteria were also observed within phagocytic cells 
in the subepithelial location in the lamina propria. Bacteria were rarely found in 
lymphoid follicles that compose Peyers patches at any time point. A few 
infiltrating inflammatory cells within the lamina propria were occasionally 
observed at later time points, most of which were macrophages and 
lymphocytes, with rare occurrence of neutrophils (Fig. 4D).  The lamina propria 
and submucosa were often expanded by clear spaces accompanied by 
breakdown of collagen fibers indicating edema (Fig. 4D). Cells with features of 
apoptosis and phagocytic cells containing apoptotic bodies were commonly seen 
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in all samples, but more often in infected tissues regardless the bacterial strain, 
yet bacteria were not found to be associated with these cells.   
 
 
Figure 5: Transmission electron micrographs of normal enterocytes in the tip of villi from an 
uninfected control sample (A) and WT-infected samples (B-D). Upon contact with the apical 
portion of enterocytes, S. typhimurium disrupted the brush border and induced membrane ruffle 
formation (B). Infected cells showed evidence of degeneration including cytoplasmic swelling, 
rarefaction, loss of organelles, and dilation of endoplasmatic reticulum (C). The lamina propria 
often exhibited clear spaces with breakdown of collagen fibers (edema) and rare neutrophils (D). 
1 hour post-infection. BLAD calf (CD18 -/-). 
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Analysis of mucosal surface by scanning electron microscopy 
confirmed the presence of villi blunting beginning at 4 HPI in WT-infected 
samples and 8 hours in MT-infected samples. At 12 hours, both strains induced 
marked villi blunting and luminal fibrin exudation (Figs. 5 A-B). 
 
 
Figure 6: Scanning electron micrograph of the intestinal mucosa depicting normal appearance of 
villi in an uninfected control sample at 1 hour post-infection (A) compared to an WT-infected 
sample at 12 hours post-infection (B). Note in (B) the severe villi atrophy and luminal fibrin 
exudation (pseudomembrane formation). BLAD calf (CD18 -/-).  
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Tissue invasion and fluid secretion 
  
 
The results of S. typhimurium invasion in the intestinal samples are 
summarized in Figure 6. In general for both WT and MT bacteria, a higher 
number of organisms invaded the mucosa in BLAD calves as compared to 
control; however, the difference was not statistically significant at most time 
points except to WT-infected tissues at 4 HPI. The WT strain was also found to 
be significantly more invasive than MT bacteria in control calves at all time 
points, except 1 hour post-infection. In contrast, in BLAD calves, the WT strain 
was significantly more invasive than MT at 1 HPI only. 
Quantification of the amount of fluid accumulated within the 
intestinal lumen for each sample demonstrated that fluid secretion in WT-infected 
samples is significantly reduced in BLAD calves compared to control calves at 8 
and 12 HPI (Fig. 7). While control calves had significantly increased fluid 
secretion in WT compared to MT-infected samples at late time points (4 and 8 
hours), a significant difference between WT and MT-infected tissues in BLAD 
calves was observed only at 4 hour post-infection (Fig. 7). 
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Figure 7: Wild type (WT) and mutant (MT) S. typhimurium mucosal invasion in BLAD (CD18 -/-) 
and control calves (CD18 +/+) at 1, 4, 8 and 12 hours post-infection. Conditions labeled with the 
same number are statistically different (P < 0.05). 
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Figure 8: Wild type (WT) and mutant (MT) S. typhimurium fluid accumulation in BLAD (A) and 
control calves (B) at 1, 4, 8 and 12 hours post-infection. Conditions labeled with the same number 
are statistically different (P < 0.05). 
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Chemokine and cytokine profile 
 
 
Quantitative gene expression of major pro-inflammatory cytokines 
(IL-1β & TNF-α) and chemokines (IL-8 & GRO-α) was determined by Real-Time 
PCR technology. IL-8 gene expression in WT-infected samples was significantly 
higher in BLAD compared to control calves at 4 and 12 HPI (Fig. 8).  In addition, 
samples from BLAD calves had significant differences in IL-8 gene expression 
between WT and MT-infected tissues (Fig. 8), showing higher expression in MT 
and WT infected samples at 1 and 8 HPI respectively (Fig. 8). Gene expression 
of GRO-α was significantly higher in control calves compared to BLAD in WT-
infected samples at 12 HPI only (Fig. 9). In addition, at this time point, GRO-α 
gene expression in control calves was higher in WT compared to MT-infected 
samples at 12 HPI (Fig. 9). 
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Figure 9: Wild type (WT) and mutant (MT) S. typhimurium-induced IL-8 gene expression in BLAD 
(A) and control calves (B) at 1, 4, 8 and 12 hours post-infection. Conditions labeled with the same 
number are statistically different (P < 0.05). 
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Figure 10: Wild type (WT) and mutant (MT) S. typhimurium-induced GRO-α gene expression in 
BLAD (A) and control calves (B) at 1, 4, 8 and 12 hours post-infection. Conditions labeled with the 
same number are statistically different (P < 0.05). 
 
 
Significant statistical differences in IL-1β gene expression were not 
observed comparing any samples from BLAD and control calves (Fig. 10). 
Although not significant, the levels of IL-1β gene expression was generally higher 
in control animals than BLAD calves for most samples at most time points (Fig. 
10). The gene expression of TNF-α, another major pro-inflammatory cytokine, 
was variable depending on the animal genotype. At 1 HPI, WT-infected samples 
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had higher expression in BLAD compared to control calves whereas the 
opposite, i.e. higher expression in control than BLAD, was detected in WT-
infected samples at 4 HPI (Fig. 11). 
A
0
50
100
150
1h 4h 8h 12h
Time post-inoculation (hours)
WT
MT
 
B
0
50
100
150
1h 4h 8h 12h
Time post-inoculation (hours)
WT
MT
 
Figure 11: Wild type (WT) and mutant (MT) S. typhimurium-induced IL-1β gene expression in 
BLAD (A) and control calves (B) at 1, 4, 8 and 12 hours post-infection. Conditions labeled with the 
same number are statistically different (P < 0.05). 
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Figure 12: Wild type (WT) and mutant (MT) S. typhimurium-induced TNF-α gene expression in 
BLAD (A) and control calves (B) at 1, 4, 8 and 12 hours post-infection. Conditions labeled with the 
same number are statistically different (P < 0.05). 
 
 
Discussion 
 
 
The acute morphologic changes induced by S. typhimurium 
infection in calves as well as the profile of cytokines and chemokines have been 
well documented in previous studies using the ligated intestinal loop model (32, 
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78, 163, 164, 221, 223). Currently, the massive tissue influx of neutrophils is 
considered the histopathological hallmark of typhoidal salmonellosis (190). The 
typical neutrophilic influx has been suggested to represent the major event 
triggering tissue necrosis and diarrhea (161, 164, 222). Here we described the 
morphologic changes induced by S. typhimurium infection in BLAD calves, which 
essentially lack tissue neutrophils.  
Our findings demonstrate remarkable morphologic differences in 
the intestine in the absence of tissue influx of neutrophils. While the first 
histologic lesions of villi blunting in normal calves (CD18 +/+) appeared as early 
as 15 minutes post-infection (164),  blunting in BLAD calves was absent at 1 HPI 
and first detected at 4 HPI (WT-infected samples only). Moreover, the MT strain, 
well-known for its attenuated pathogenicity, induced the first detectable blunting 
at 8 HPI. In addition to blunting, detachment of epithelial cells in BLAD calves 
infected with WT strain was mainly observed at 8 HPI with only occasional 
occurrence at 4 hours. In contrast, this finding was commonly observed at 3 HPI 
(164) and first detected as early as 1 hour in normal calves (221).  
Although evidence of neutrophil extravasation in BLAD calves with 
experimental Pasteurellosis has been reported to occur in the lungs (2, 3, 5), 
significant mucosal neutrophilic inflammation was not observed in any of the 
infected intestinal tissues. When present, neutrophils were limited to the 
perivascular connective tissue in the submucosa at 8 and 12 HPI, always 
associated with vascular lesions. Our data suggest that submucosal 
extravasation of neutrophils was caused by loss of vascular integrity secondary 
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to vasculitis, formation of fibrin thrombi, and vascular necrosis. Vasculitis and 
thrombosis has been previously reported in BLAD calves with dermatitis (6).  
The typical widespread necrosis of the uppermost mucosa with 
complete loss of the intestinal epithelium extending to crypts reported at 8-12 
hours in S. typhimurium-infected calves (187, 222) was not observed in BLAD 
calves. In contrast, necrosis in BLAD samples was limited to tips of villi, 
progressing to the basolateral surface, and a few scattered foci in the lamina 
propria, presumably reflecting the pattern of bacterial invasion and dissemination. 
Instead of massive mucosal necrosis, the most impressive morphologic change 
in BLAD tissue at 12 HPI was complete atrophy and fusion of villi. This finding 
indicates that changes in villi morphology during non-typhoidal salmonellosis can 
be induced by epithelial invasion in the absence of neutrophilic inflammation. 
Ultrastructurally, lesions in enterocytes induced by S. typhimurium infection in 
BLAD calves, including attachment and disruption of the brush border, apical 
membrane ruffling formation, and cellular degeneration, were similar to the ones 
reported in normal calves submitted to similar experimental conditions (164). 
Moreover, the published data identifying cell tropism of S. typhimurium for M-
cells in the follicle-associated epithelium of Peyers patches and epithelial cells at 
the tips of absorptive villi (54, 164) was confirmed in our BLAD samples. 
The most remarkable and surprising morphologic difference 
between the typical lesions of S. typhimurium-induced enteritis in normal calves 
compared to animals in this study was the complete absence of Peyers patches 
lesions in BLAD calves. Acute salmonellosis in calves is typically associated with 
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lymphocyte depletion in Peyers patches follicles (164) progressing to necrosis in 
chronic stages of infection (215). The absence of significant lesions in BLAD 
calves suggests that Peyers patch necrosis in salmonellosis occurs as a 
consequence of neutrophilic infiltration within lymphoid follicles as opposed to 
bacterial infection of cells being transported into the lymphoid follicles. This 
hypothesis is supported by evidence that neutrophilic infiltration in Peyers patch-
infected samples precedes lymphoid depletion and necrosis in calves (164). 
Invasion of S. typhimurium in bovine ligated ileal loops is 
dependent on the synergistic effects of TTSS-1-encoded effector proteins SipA, 
SopA, SopB, SopD, SopE, and SopE2 (149, 223). TTSS-1 effectors induces 
rearrangements in the host cell cytoskeleton resulting in apical membrane ruffle 
formation and macropinocytosis of the bacteria (52, 61). In this study, mucosal 
invasion of Salmonella was generally increased in BLAD compared to control 
calves, though statistically significant at only 4 HPI. In addition, for most time 
points, the MT strain carrying simultaneous mutations in the five major TTSS-1-
encodes genes was not found to be significantly less invasive than the WT in 
BLAD calves as opposed to the higher invasiveness of WT compared to MT 
bacteria as confirmed by our data from control calves and as reported in the 
literature (221, 222). Collectively, these data suggest that tissue influx of 
neutrophils partially reduce mucosal invasion of WT S. typhimurium and largely 
contribute to prevention of invasion of the mutant strain. Our finding of no 
significant difference in invasiveness between WT and MT strain in control 
animals at 1 hour post-infection corroborates this concept, because the number 
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of tissue neutrophils to prevent MT invasion is markedly reduced at 1 hour post-
infection compared to later time points. Even though all intestinal samples were 
serially washed in three different PBS solutions to reduce extracellular 
organisms, a possible limitation of our methodology to determine invasion is the 
absence of antibiotic treatment (gentamicin) of collected mucosal samples before 
culture to eliminate non-invaded bacteria potentially attached to the mucosa or 
luminal secretory material (mucus, fibrin, etc) (150). On the other hand, the 
consequences of gentamicin treatment to the intestinal mucosa and resident flora 
during the time between processing of samples and culture have not been 
determined and could potentially interfere with invasion. For instance, non-
typhoidal salmonellosis in mice, which typically develop typhoidal systemic 
disease when infected by S. typhimurium, can be induced experimentally by oral 
treatment with high doses of the antibiotic streptomycin followed by infection with 
S. typhimurium (77), indicating that disruption of normal flora by antibiotics can 
dramatically change the host-agent interaction and potentially induce unexpected 
results. 
The mechanism responsible for fluid secretion and diarrhea in non-
typhoidal models of salmonellosis remains to be elucidated. Studies in bovine 
ligated ileal loops strongly support an exudative mechanism rather than secretory 
diarrhea (chloride secretion) as the most likely mechanism (222). Accordingly, 
the massive intestinal influx of neutrophils in caves infected with S. typhimurium 
results in necrosis with loss of epithelial integrity and diarrhea by an exudative 
mechanism (222). This hypothesis is supported by the pronounced loss of 
  
50
plasma proteins after infection of calves by S. typhimurium indicating increased 
intestinal permeability associated with severe intestinal protein loss during 
infection (160). Our data provide strong evidence that fluid accumulation in BLAD 
calves is significantly reduced compared to control calves in late time points 
when inflammation is normally most severe, i.e. at 8 and 12 HPI. As with 
bacterial invasion, the markedly different degree of responses between WT and 
MT-infected samples observed in control animals were generally less evident in 
BLAD animals, supporting the hypothesis that neutrophil influx plays a crucial 
role in the pathogenesis of both strains, especially preventing pathologic effects 
caused by the MT strain. Our findings support the hypothesis of exudative 
diarrhea secondary to inflammation as the major contributor for fluid secretion in 
non-typhoidal salmonellosis. It is important to realize; however, that while 
markedly reduced, fluid secretion in BLAD calves still occurred. It is yet to be 
determined if the mild fluid accumulation observed in BLAD animals results from 
either secretory mechanisms, secondary to the necrosis and vascular lesions , or 
a combination thereof as commonly observed at 8 and 12 hours post-infection. 
The type of inflammatory infiltrate that characterize a disease is 
controlled in part by the profile of inflammatory cytokines and chemokines (110). 
The pro-inflammatory cytokines IL-1β and TNF-α as well as potent neutrophil 
chemoattractants, the CXC chemokines IL-8 and GRO-α, have been suggested 
to play a major roles during S. typhimurium-induced enteritis and diarrhea in 
calves (161, 164, 222). Besides being often expressed in the bovine model of 
non-typhoidal salmonellosis, IL-8 gene expression is also induced by human 
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epithelial cell lines by the S. typhimurium TTSS-1 (85). We found that gene 
expression of IL-8 in WT-infected samples is significantly higher in BLAD than in 
control animals at 4 and 12 HPI. A possible interpretation of this finding is that 
the absence of tissue neutrophils in BLAD triggers a positive feedback 
mechanism for production of more IL-8 via unknown pathways in an attempt to 
recruit neutrophils necessary to control infection. This finding also suggests that 
neutrophils are unlikely to be the major source of IL-8 during S. typhimurium 
infection in calves since increased gene expression in BLAD occurred in the 
absence of significant tissue influx of neutrophils. Studies using the bovine 
ligated ileal loop model have identified the GRO-α chemokine as the major 
chemoattractant for neutrophils during S. typhimurium-induced enteritis (221). 
Our data on GRO-α gene expression in control calves confirm its high expression 
levels, up to 80 fold increase over control in WT-infected samples, especially in 
the later stages of acute infection, i.e. at 12 HPI. This finding suggests that the 
massive influx of neutrophils seen at the late phase of acute infection is mainly 
driven by GRO-α. In BLAD calves; however, the GRO-α gene expression at WT-
infected samples at this late stage of infection was significantly reduced 
compared to control indicating that the neutrophil influx potentially may play a 
role in triggering GRO-α gene expression in the later phase of acute infection by 
either directly secreting this chemokine or stimulating its production in other cell 
types indirectly. IL-1β and TNF-α are classic pro-inflammatory cytokines 
increased during Salmonella infection in all organs studied to date using in vivo 
models of infection (40, 102, 164). Extensive evidence from studies in mice 
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indicates that these cytokines are essential for host defense against Salmonella 
infection (41). In bovine ligated ileal loops infected with S. typhimurium, the gene 
expression of these two cytokines was determined by conventional reverse 
transcription PCR. Accordingly, the expression of IL-1β was elevated at 3 and 6 
HPI, whereas no changes in gene expression was detected for TNF-α after 
infection (159). Our data show that the gene expression levels of IL-1β in BLAD 
calves were lower than those of control animals, especially in WT-infected 
samples, at 2 hours and later time points. These data were expected in view of 
the essentially absent tissue inflammation in the BLAD calves; however, the 
differences in gene expression observed were not statistically different. The lack 
of statistical significance in the different expression levels of IL-1β between BLAD 
and control animals can be explained by the high standard deviation observed in 
our data as a result of marked individual variability. More experimental samples 
are necessary to increase the statistical power and confirm our findings regarding 
IL-1β  gene expression. The TNF-α gene expression in our BLAD samples was 
variable in WT-infected samples, with significantly higher expression in BLAD at 
1 HPI, but with the opposite relationship, i.e. higher expression occurring in 
control animals at 4 hour post-infection. These results, combined with our finding 
of no significant differences in TNF-α gene expression between BLAD and 
control calves at later time points suggest that neutrophil influx likely plays a 
minor role in the gene expression of this cytokine during S. typhimurium-induced 
enteritis in calves. 
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In conclusion, infection by S. typhimurium of ligated ileal loops in 
calves with Bovine Leukocyte Adhesion Deficiency results in markedly distinct 
morphologic and immunologic changes compared to normal animals negative for 
the BLAD defect. The most important differences include essentially the absence 
of typical S. typhimurium-induced neutrophilic enteritis, unique pattern and 
reduced magnitude of necrosis, and differential gene expression profiles of major 
neutrophil chemokines and pro-inflammatory cytokines. These differences in 
BLAD calves are associated with a significantly increased bacterial invasion and 
reduced fluid accumulation supporting the hypothesis that S. typhimurium-
induced diarrhea in normal calves is primarily exudative in nature and caused by 
the massive tissue influx of neutrophils. This new evidence enhances our 
understanding of the pathogenesis of diarrhea of human and ruminant non-
typhoidal salmonellosis. 
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CHAPTER III 
 
 
ANALYSIS OF CYTOKINE PROFILES IN S. Typhimurium-INFECTED 
CALVES WITH BOVINE LEUKOCYTE ADHESION DEFICIENCY BY LASER 
CAPTURE MICRODISSECTION 
 
 
Introduction 
 
 
Cytokine and chemokine activation and signaling largely mediated 
the type of inflammatory response induced by the host-agent interaction during in 
vivo Salmonella infections (31). Studies in bovine ligated ileal loops infected with 
Salmonella enterica serovar Typhimurium (hereafter S. typhimurium), a suitable 
model for human salmonellosis (189), provide strong evidence that the massive 
tissue influx of neutrophils, followed by necrosis and diarrhea that characterize S. 
typhimurium-induced enteritis, is driven mainly by activation of pro-inflammatory 
cytokines and potent neutrophil chemokines (CXC chemokines) activated upon 
infection of the host (161, 221, 222). In contrast, infection of mice by S. 
typhimurium elicit strikingly distinct chemokine gene expression in the intestine 
compared to bovine, characterized by preferential activation of mononuclear cell 
chemoattractants (CC chemokines), which results in the typical mononuclear 
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enteritis in the absence of necrosis and diarrhea (221). Taking together these 
studies in bovine and mice indicate that the nature and dynamics of pro-
inflammatory cytokine and chemokine activation during infection play a major role 
in the pathogenesis of S. typhimurium-induced diarrhea. 
The role of chemokines in the pathogenesis of Salmonellosis has 
also been investigated by in vitro studies, which identified epithelial secretion of 
IL-8 as a major triggering event in neutrophil recruitment (92). Studies using 
polarized human intestinal cell lines found that Salmonella releases the protein 
flagellin that binds to toll-like receptor 5 (TLR5) restricted to the basolateral 
surface of epithelial cells resulting in activation of a signaling pathway leading to 
IL-8 secretion (65, 66). While migration of neutrophils from the microvasculature 
through the endothelium to the submucosa and to the basolateral surface of the 
epithelial monolayer appear to be dependent on IL-8 secretion (119), neutrophil 
migration across the epithelial barrier into the lumen appears to be driven by a 
small 1-3 KDa chemoattractant, previously known as known as pathogen-elicited 
epithelial chemokine (PEEC), recently renamed hepoxilin A3 (120, 129). 
Hepoxilin A3 was found to be secreted solely in the apical compartment of 
polarized monolayer of intestinal epithelial cells in response to Salmonella 
activation of protein kinase C (PKC) (107).  
To better understand the dynamics of gene activation and anatomic 
localization of major pro-inflammatory cytokines and neutrophil CXC chemokines 
during S. typhimurium-induced enteritis, we employed the Laser Capture 
Microdissection technology (LCM) in the ligated ileal loop model in calves with 
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bovine leukocyte adhesion deficiency (BLAD). Calves affected by the BLAD 
condition are born with a single point mutation in the common β2 integrin subunit 
CD18 resulting in deficient expression of all four classes of β2 integrin (CD11a, b, 
c, d/CD18) on the surface of leukocytes (132). The defect renders neutrophils 
incapable to extravasate from blood vessels and reach the extracellular matrix 
during inflammation (5, 7). In addition to deficient extravasation, BLAD calf 
neutrophils have marked functional abnormalities including severely decreased 
adherence, chemotactic movements, phagocytosis, luminol-dependent 
chemiluminescent response, and O (2-)- producing activities (135). The use of 
the BLAD calf in this study, which is essentially a model of neutrophil knockout, 
was employed to better understand the influences of neutrophilic influx over the 
cytokine and chemokine activation milieu during S. typhimurium-induced 
enteritis. 
 
 
Material and Methods 
 
 
Bacterial strains and growth conditions 
 
 
Strains of S. typhimurium used in this study included the Wild Type 
strain IR715 (ATCC 14028 wild type nal) (178) and the mutant strain ZA21 
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(∆sipAsopABDE2 - ATCC 14028 nal) (223). All strains were grown in Luria-
Bertani (LB) medium with nalidixic acid antibiotic (50 mg/liter) under agitation 
(250 rpm) overnight at 37oC; 50 µl of the culture was inoculated into 5ml of fresh 
LB medium and sub-cultured for additional 4 hours before inoculation. 
 
 
Animals, surgical procedure, and sampling 
 
 
BLAD Holstein calves, 5 weeks of age, one male and one female, 
weighting approximately 45 to 55 Kg were used in these experiments. The two 
calves were homozygous for the BLAD defect (CD18 -/-) as determined by a 
PCR-based DNA test combined with restriction enzyme analysis (99, 171). 
Embryo transfer technology (168) was used to generate the BLAD calves. 
Embryos were donated the USDA/ARS National Animal Disease Center (NADC) 
 Ames, IA. The calves were kept clinically healthy before the experiments at the 
Large Animal Hospital of the College of Veterinary Medicine, Texas A&M 
University, College Station  TX and negative for Salmonella spp. as determined 
by fecal culture using enrichment in tetrathionate broth (Difco, Detroit, MI). 
Calves were fed antibiotic-free milk replacer twice a day, water ad libitum, and 
fasted 24 hours prior to experimental surgeries. The ligated ileal loop surgical 
procedure was employed as previously described (164, 166). Briefly, anesthesia 
was induced with propofol (Abbot Laboratories, Chigaco, IL) followed by 
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placement of endotracheal tube and maintenance with isofluorane (Abbot 
Laboratories, Chigaco, IL) for the duration of the experiment. A laparotomy was 
performed, the ileum and jejunum were exposed and 16-20 loops, 5 to 8 cm long, 
were ligated in the ileum and distal jejunum, intercalated with 1-2 cm loops. The 
loops were injected with 3 ml of either sterile LB broth (control loops) or LB 
containing approximately 0.75 x 109 colony-forming units (cfu) of the S. 
typhimurium strains previously described. Loops were replaced into the 
abdominal cavity and excised at 1 hour post-infection (HPI). Samples for 
immunohistochemistry (IHC), quantitative Real-Time PCR (qRTPCR), and Laser 
Capture Microdissection (LCM) were collected.  
 
 
Real-time polymerase chain reaction (qRTPCR) 
 
 
As a source of host RNA, six to eight 6 mm biopsy punches were 
taken from the intestinal tissue including Peyers patches. Punches were 
immediately cleaned to remove debris, minced into small pieces with a sterile 
scalpel or razor blade, immersed in 4°C 500 µl of TRI-reagent® (Ambion, Foster 
City, CA) and further homogenized using a tissue grinder. The RNA was 
extracted according to TRI-reagent manufacturer instructions, the pellet was re-
suspended in nuclease-free water (Ambion, Foster City, CA), and contaminating 
DNA was removed by RNase-free DNase I treatment (Ambion, Foster City, CA) 
  
59
according to manufacturers instructions. Samples were stored at -80oC until 
used. The resultant DNA-free RNA was quantified using a NanoDrop® ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE) and assessment 
of RNA quality was determined using an Agilent 2100 Bioanalyser (Agilent 
Technologies, Santa Clara, CA).  
Selected RNA samples of adequate quality from each condition 
was used to determine the gene expression levels of IL-8, GRO-α, IL-1β, and 
TNF-α by qRTPCR as previously described (221). Briefly, 2 µg of RNA was 
reverse transcribed at 48 oC for 30 min with random hexamer primers and 
Multiscribe Reverse Transcriptase (Applied biosystems, Foster City, CA). The 
resultant cDNA at concentration of 40 ηg per sample was mixed with 4 SmartMix 
beads per sample (Cepheid, Sunnyvale, CA), SYBRGreen-I 0.2x (Invitrogen 
Corporation, Carlsbad, CA) and 500 nM of each primer set (Table 2). The 
qRTPCR reaction was performed using a Smart Cycler II (Cepheid, Sunnyvale, 
CA). The quantitative gene expression of each cytokine and chemokine was 
normalized to the internal control glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). The normalized levels of gene expression in infected tissues were 
calculated relative to uninfected control tissues as previously described (221). 
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Laser capture microdissection 
 
 
The same BLAD calves submitted to the previously described 
experimental surgeries were also used as source of host RNA for LCM.  The 
intestinal samples collected at surgery (1 HPI) were placed in a cryomold 
containing Optimal Cutting Temperature (OCT) compound and immediately 
transferred to dry ice followed by storage at -80oC until sectioning. Frozen blocks 
were trimmed at 8 µm under RNAse-free conditions using the cryostat UltraPro 
5000 (Vibratome, St. Louis, MO). Trimmed sections were transferred to a cold 
adhesive-coated glass slide at 1x adhesive concentration by using the 
CryoJane® Tape-Transfer system (Instrumedics Inc, St. Louis, MO) according to 
manufacturers instruction. Resulting tissue sections were fixed in 70% ethanol, 
stained by HistoGene LCM frozen section staining kit (Molecular Devices 
Corporation, Sunnyvale, CA), and subjected to LCM using the PixCell II system 
(Molecular Devices Corporation, Sunnyvale, CA). Enterocytes of absorptive villi 
and crypts, plus the entire domed villi were captured onto CapSure Macro LCM 
caps (Molecular Devices Corporation, Sunnyvale, CA) (18, 43, 44, 49). Domed 
villi included the lining enterocytes of non-absorptive villi (follicle-associated 
epithelium) and underlying lamina propria.  
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LCM RNA isolation, amplification, and gene expression 
 
 
Approximately 1000 cells were captured for each one of the 
histologic units, i.e. villi tips, crypts, and domed villi, in each sample. RNA from 
captured cells was isolated using PicoPure RNA Isolation Kit (Molecular Device 
Corporation, Sunnyvale, CA) (125).  RNA quality and quantity from captured cells 
was evaluated using an Agilent 2100 Bioanalyser (Agilent Technologies, Santa 
Clara, CA). RNA samples of appropriate quality were selected and 2.5 ηg per 
sample was submitted to two rounds of amplification using RiboAmp HS RNA 
Amplification Kits according to the manufacturers instructions (Molecular 
Devices Corporation, Sunnyvale, CA) (218). Gene expression of IL-8, GRO-α, IL-
1β, and TNF-α from uninfected controls, WT and MT S. typhimurium-infected 
samples were measured by qRTPCR using 500 nM of each primer set (Table 2), 
as previously described above.  
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Table 2- Primer sequences used in qRTPCR to study the gene expression of S. 
typhimurium infected bovine intestine in samples derived form the whole 
intestinal tissue including mucosa and submucosa (whole tissue) and cells 
captured by Laser Capture Microdissection (LCM). 
 
Sample type Target Primer sequencea Amplicon size (bp) 
Whole 
tissue 
GAPDH TTCTGGCAAAGTGGACATCGT 
GCCTTGACTGTGCCGTTGA 
114 
 
 GRO-α CACTGCGACCAAACCGAAGT 
GTATCAAGAAGCTCGTTCCAT 
153 
 IL-8 TGCTTTTTTGTTTTCGGTTTTTG 
AACAGGCACTCGGGAATCCT 
71 
 IL-1β CCAGCCTGGCAAAAACCAT 
CCGGAAATTGGTTCCACAGT 
201 
 TNF-α GTTCCTCACCCACACCATCAG 
GGTAGTCCGGCAGGTTGATC 
283 
 
LCM GAPDH TTCCTGGTACGACAATGAATTT 
CAGTGTGGCGGAGATGGGGCACG 
162 
 GRO-α CACTGTTAATGTAGGGAATGTAT 
TGTCCAAGGGATATTTAGATCATTG 
147 
 IL-8 AATCTTGAGACTGTCTTTCC 
TAAAGTTTATGTTCGAATACACAA 
139 
 IL-1β CCAGCCTGGCAAAAACCAT 
CCGGAAATTGGTTCCACAGT 
201 
 TNF-α GTTCCTCACCCACACCATCAG 
GGTAGTCCGGCAGGTTGATC 
283 
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aSequences for bovine genes were obtained from GenBank. Top row represents 
forward primers and bottom row shows reverse primers. 
 
 
Immunohistochemistry 
 
 
Intestinal samples for immunohistochemistry (IHC) were fixed in 
neutral 10% buffered formalin, processed according to routine procedures for 
paraffin embedding, sectioned at 4-5 µm, and submitted to IHC, which was 
performed using the MACH 2 polymer detection kit (Biocare Medical, Concord, 
CA) according to manufacters instructions. For in situ detection of S. 
typhimurium, Salmonella O group B antiserum (BD biosciences, San Jose, CA) 
was used.  The primary antibody was substituted with a universal rabbit control 
(DakoCytomation, Carpinteria, CA) and DAB (3,3-diaminobenzidine) 
(DakoCytomation, Carpinteria, CA) was used as the chromogen. 
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Statistical analysis 
 
 
The gene expression of cytokines and chemokines were analyzed 
by calculation of geometric means and standard deviation, followed by the use of 
a Students t test to determine differences with statistical significance (p < 0.05). 
 
 
Results 
 
 
The LCM technique 
 
 
The LCM technique was found to be adequate to generate good 
quality RNA as accessed by the Agilent bioanalyser (data not shown).  The cells 
captured, approximately 1000 per sample, yielded 4.0 to 53.0 ηg of total RNA. 
For each sample, 2.5 ηg of RNA generated between 3.2 and 42.0 µg of amplified 
mRNA used for qRTPCR. Figure 13 shows examples of the histologic sections 
used during LCM and all three captured histologic units. 
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Figure 13: Examples of domed villi (A-C), crypts (D and E), and tips of absorptive villi (F-H) 
captured by LCM. Histologic fields containing cells of interest were selected (A, D, and F) and 
cells were captured in CapSure Macro LCM caps (C, E, and H). B and G illustrate missing cells 
captured after the laser was applied. 
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Chemokine and cytokine profile in the intestine 
 
 
For the sake of comparison with the gene expression obtained by 
the LCM, the expression of the same cytokines (IL-1β & TNF-α) and neutrophil 
chemokines (IL-8 & GRO-α) at the same time point and same calves as the LCM 
experiments (1 HPI) was also determined at whole intestinal samples by 
qRTPCR. This was accomplished using RNA isolated from heterogeneous ileal 
samples that included the mucosa, submucosa, and Peyers patches.  Results 
are summarized in Figure 14. At the initial stages of acute infection, represented 
here by 1 HPI, GRO-α had the highest gene expression levels for both WT and 
MT-infected samples, followed a mild up-regulation of IL-8 also in both WT and 
MT-infected tissues. The gene expression of the pro-inflammatory cytokines IL-
1β and TNF-α were reduced when compared to the levels attained by the two 
chemokines, especially GRO-α. In addition, the gene expression of IL-1β & TNF-
α in WT and MT-infected samples had similar intensities to each other as 
opposed to what was detected for IL-8 & GRO-α.  
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Figure 14: Wild type (WT) and Mutant (MT) S. typhimurium-induced cytokine and chemokine 
gene expression in the ileum of BLAD calves at 1 hour post-infection.  
 
 
Chemokine and cytokine profile in captured cells (LCM) 
 
 
Gene expression of all cytokines and chemokines included in this 
study, except TNF-α, were detected by qRTPCR in all distinct groups of cells 
captured by LCM (Fig. 15). For all three distinct inflammatory mediators detected, 
i.e. IL-8, GRO-α, and IL-1β, enterocytes of crypts presented the highest levels of 
gene expression compared to enterocytes of villi tips and cells of domed villi in 
WT-infected samples (Fig. 15). The gene expression of all cytokines was 
predominantly lower in MT-infected samples compared to WT-infected in crypts 
(Fig. 15). Enterocytes of villi tips and cells of domed villi demonstrated similar 
levels of gene expression for all cytokines in both WT and MT-infected samples 
(Fig. 15).  
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Figure 15: Wild type (WT) and Mutant (MT) S. typhimurium-induced IL-8 (A), GRO-α (B), and IL-
1β (C) gene expression in villi tips, crypts, and domed villi in the ileum of BLAD calves at 1 hour 
post-infection.  
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Immunohistochemistry 
 
 
The distribution of invading S. typhimurium was investigated by IHC 
at 1 HPI. Our results indicate that WT and MT strains have an equal pattern of 
invasion in the ileal mucosa. The most common sites of S. typhimurium invasion 
were the basolateral enterocytes of absorptive villi and the follicle-associated 
epithelium of domed villi (Figure 16), followed by fewer bacteria observed within 
enterocytes of villi tips. The organism was also infrequently detected in the 
lamina propria of absorptive villi and domed villi.  
 
 
Discussion 
 
 
Infection with Salmonella species causes significant immune 
activation and consequent inflammation often resulting in host damage. While 
Salmonella-induced inflammatory responses contribute to the nature and severity 
of the immunopathology, the inflammatory infiltrates are also clearly critical for 
control of infection (31). The ultimate outcome of this competition, which may 
benefit the host or the bacteria, is highly influenced by the set of cytokines and 
chemokines produced by the host in response to infection (177). For this reason, 
understanding of the pathogenesis and dynamics of cytokine and chemokine 
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activation during infection represents an important step in developing novel 
therapeutic approaches for Salmonella infection.  
 
 
 
 
Figure 16: Immunohistochemistry for Salmonella O antigen in bovine ligated ileal loops of control 
uninfected (A) and S. typhimurium WT-infected tissues (B and C). Note the preferential 
distribution of invading bacteria along enterocytes of basolateral villi (B) and follicle-associated 
epithelium of domed villi (C). 1 hour post-infection. BLAD calf (CD18 -/-). 
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The gene expression profiles of cytokines and chemokines induced 
by Salmonella infection have been extensively investigated; however, the vast 
majority of these studies employed in vitro cell culture systems or in vivo mouse 
models of infection (41). This type of information in the bovine models of human 
salmonellosis is proportionally scarce compared to the information derived from 
cell culture systems and mice. The data generated in our work is innovative, 
because we used calves with leukocyte adhesion deficiency unable to mount an 
adequate neutrophilic response against S. typhimurium infection, which is 
considered the hallmark of Salmonella-induced enteritis and diarrhea (190). The 
lack of tissue neutrophils observed in our experimental animals allowed an 
enhanced analysis and characterization of the innate immune response induced 
by Salmonella infection alone without the influences of the neutrophilic exudate 
and massive necrosis occurring in the later stages of acute infection in the bovine 
model. Despite the fact that significant statistical differences were not observed 
in any comparison between genetic expression levels of cytokine, our data 
revealed interesting tendencies relevant to the understanding of salmonellosis. 
The reduced number of calves available for the LCM studies accounts for the 
lack of statistical significance in our data. 
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The most interesting finding is our study was the preferential 
genetic up-regulation of all cytokines detected (IL-8, GRO-α, and IL-1β) in crypts 
when compared to those in tips and domed villi. Previous in situ hybridization 
studies using regular calves, i.e. negative for the BLAD defect, infected by S. 
typhimurium found that GRO-α transcripts were detected primarily in enterocytes 
lining the intestinal crypts, at the base of absorptive villi, and in the follicle-
associated epithelium of lymphoid nodules with minimal detection in tips of 
absorptive villi (221). These findings of preferential localization of GRO-α 
transcripts strongly support our data. The base of absorptive villi was not used in 
our LCM studies; however, the gene expression profiles of cytokines in these 
enterocytes are likely to be similar to those in crypt enterocytes, because the yet 
immature enterocytes lining the base of absorptive villi are continuous and 
closely related to that of the crypts (219). The enterocytes covering the tips of villi 
are also continuous with enterocytes lining the base of absorptive villi, but unlike 
those lining the basolateral surface, the enterocytes of the tips of the villi have 
the highest degree of maturation as they migrate from crypts (219), presumably 
accounting for the differences in cytokine gene expression observed between 
crypts and tips of villi.  
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The gene expression levels in WT-infected samples detected in the 
LCM study correlates well with the gene expression observed in the whole 
intestinal samples derived from the same animals, confirming the highest 
expression levels for GRO-α followed by IL-8 and IL-1β. However, the IL-1β gene 
expression in crypts (approximately 15 fold) was markedly elevated to levels 
above the IL-8 gene expression (approximately 7 fold) in WT-infected samples as 
opposed to the reverse tendency observed in the data from whole intestinal 
samples. These data suggest that crypts are likely the principal source for the 
vast majority of the relatively low expression of IL-1β observed in bovine 
intestinal samples infected by S. typhimurium. The contribution of epithelial cells 
to IL-1β gene expression induced by Salmonella infection was largely unknown 
before this study, because data available to date focused to report IL-1β up-
regulation limited to macrophages (41, 155). In vitro studies demonstrated that 
epithelial cells are a major source of IL-8 gene expression during Salmonella 
infection (42, 97, 118), but the prioritized contribution of crypt enterocytes 
compared to tips and domed villi found in this work was not previously reported in 
the literature.  
Several studies highlight the importance of TNF-α during 
salmonellosis indicating that this pro-inflammatory cytokine plays a protective 
role against Salmonella infection (41). Our data on whole intestinal samples 
support up-regulation of this cytokine in the early stages of acute infection, yet its 
gene expression levels were relatively low compared to GRO-α and IL-8. 
Interestingly, this cytokine was not be detected in the LCM studies despite 
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several attempts of optimization using distinct sets of primer sequences and 
distinct PCR conditions. Our data suggest that none of the cells evaluated by 
LCM, including enterocytes of villi tips and crypts, are significant sources of TNF-
α gene expression in vivo in contrast to in vitro studies indicating up-regulation of 
TNF-α in human intestinal epithelial cell lines infected by Salmonella (97). In 
addition, since tissue influx of neutrophils was not present in the whole intestinal 
samples, our data suggest that neutrophils were also not a significant source of 
TNF-α gene expression during infection. 
A recent investigation demonstrated that the gene expression of 
GRO-α and IL-8 in MT-infected samples was significantly reduced compared to 
that of WT-infected samples in normal calves suggesting that expression of 
genes sipAsopABDE2 are necessary for eliciting up-regulation of these two 
major neutrophil chemokines (221). Data in our BLAD calves from whole 
intestinal samples support this finding and also indicate that down-regulation of 
these two chemokines in MT-infected samples are independent of tissue influx of 
neutrophils.  
Previous morphologic studies in bovine ligated ileal loops using 
normal (CD18 +/+) calves concluded that S. typhimurium infect a variety of 
intestinal cells with no predilection for any specific cell type (164). In contrast, M 
cells along the follicle-associated epithelium of Peyers patches have been 
demonstrated to be the target for Salmonella invasion in mice (30, 95). In BLAD 
calves, our IHC findings partially support the findings in the normal calves; 
however, bacteria in BLAD calves were predominantly detected in enterocytes of 
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basolateral villi and follicle-associated epithelium of Peyers patches when 
compared with enterocytes forming tips of absorptive villi. This partial 
discrepancy between normal and BLAD calves regarding the preferential 
localization of invasion can be attributed to the fact that data in normal calves 
originated from electron microscopy rather than IHC.  
In summary, the LCM technique allowed isolation of high quality 
RNA derived from specific groups of cells in the heterogeneous and complex 
intestinal tissue. The cell-specific RNA was then submitted to qRTPCR facilitating 
determination of precise anatomic localization of gene expression. For the first 
time in the Salmonella literature, enterocytes of crypts were identified as the 
major source of cytokines and chemokines involved in the pathogenesis of S. 
typhimurium-induced enteritis. The essential role of functional sipAsopABDE2 
genes for inducing up-regulation of these inflammatory mediators was confirmed 
by LCM data.  
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CHAPTER IV 
 
 
HOST TEMPORAL GLOBAL GENE EXPRESSION ANALYSIS IN Salmonella 
typhimurium-INFECTED CALVES WITH BOVINE LEUKOCYTE ADHESION 
DEFICIENCY  
 
 
Introduction 
 
 
The pathogenesis of non-typhoidal salmonellosis involves a highly 
complex interaction between the host and agent (31). Successful intestinal 
invasion and multiplication of Salmonella enterica serovar Typhimurium 
(hereafter S. typhimurium), one of the major etiologic agents of non-typhoidal 
salmonellosis, depends on a fine balance between expression of bacterial and 
host genes ultimately favoring disease manifestation (177). To date, most 
available information on the gene expression profiles involved in the 
pathogenesis of a successful S. typhimurium infection refers to bacterial genes 
encoding effector proteins that subvert the host defense mechanisms facilitating 
progression to disease (149). One of the most studied set of these genes, for 
instance, are the Salmonella Pathogenicity Island 1 (SPI-1)-encoded genes 
sipAsopABDE2, which act synergistically to invade host intestinal cells (111) and 
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trigger the massive tissue influx of neutrophils, considered the hallmark of S. 
typhimurium-induced diarrhea (221). Studies in the calf ligated ileal loop model, a 
well-established and useful model for non-typhoidal salmonellosis in humans 
(221), revealed that S. typhimurium carrying simultaneous mutations in 
sipAsopABDE2 exhibited markedly reduced ability to invade intestinal epithelial 
cells and markedly attenuated pathogenicity resulting only in mild neutrophilic 
enteritis and mild diarrhea (161, 201, 222). Another classic example of bacterial 
genes manipulating the host machinery are the products of the Salmonella genes 
encoded by a second pathogenicity island (SPI-2), which are responsible for 
intracellular survival, replication, and modification of host cell transport processes 
(1, 106). 
The host genes involved in the pathogenesis of non-typhoidal 
salmonellosis are beginning to be elucidated. Perhaps one of most important and 
most studied genetic contributions of the host during intestinal infection is 
activation of the innate immune recognition against Salmonella infection (177). 
Noteworthy is the expression of Toll-like receptors (TLR) in host cells upon 
infection, particularly, the expression of TLR5 in the basolateral surface of 
epithelial cells (23, 65). In vitro studies found that invading Salmonella secrete 
flagellin, which is transcytosed from the apical surface of epithelial cells by 
vesicular transport reaching the basolateral portion and activating TLR5 resulting 
in changes in host gene expression that leads to secretion of pro-inflammatory 
mediators (179). Other TLRs, like TLR2 and TLR4, have also been implicated in 
the pathogenesis of non-typhoidal salmonellosis based mostly on in vitro studies 
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(149), albeit the contribution of TLRs as well as several other host genes in the 
pathogenesis of non-typhoidal salmonellosis remain to be better characterized 
using in vivo models.  
The goal of this study is to improve our knowledge on the genetic 
contribution of the host during S. typhimurium infection by evaluating the global 
temporal transcription profiles of the bovine host by using microarray technology.  
The bovine ligated ileal loop model was used here in calves with Bovine 
Leukocyte Adhesion Deficiency (BLAD). BLAD calves are unable to mount an 
appropriate innate immune response against bacterial infections because they 
carry a genetic mutation in the common CD18 subunit of cell surface adhesion 
molecule β2 integrin, which prevents neutrophils from extravasating into the 
extravascular space during infection (62, 132, 136). These calves facilitate 
investigation of the host gene expression in the context of absent or minimal 
tissue influx of neutrophils during S. typhimurium infection. 
 
 
Materials and Methods 
 
 
Bacterial strains and growth conditions 
 
 
The strain of S. typhimurium used in this study was the Wild Type 
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IR715 (ATCC 14028 wild type nal) (178). The bacteria were grown in Luria-
Bertani (LB) medium with nalidixic acid antibiotic (50 mg/liter) under agitation 
(250 rpm) overnight at 37oC. Fifty µl of the culture was inoculated into 5ml of 
fresh LB medium and sub-cultured for additional 4 hours before inoculation. 
 
 
Animals, surgical procedure, and sampling 
 
 
A total of three BLAD Holstein calves (hereafter BLAD), 1 to 5 
weeks of age, represented by both genders, weighting approximately 35 to 55 Kg 
were used in these experiments. All BLAD calves were homozygous for the 
BLAD defect (CD18 -/-) as determined by a PCR-based DNA test combined with 
restriction enzyme analysis (99, 171). Embryo transfer technology (168) was 
used to generate all three BLAD calves present in this study. Embryos were 
donated by the USDA/ARS National Animal Disease Center (NADC)  Ames, IA. 
The calves were kept clinically healthy before experimental surgeries at the 
Large Animal Hospital of the College of Veterinary Medicine, Texas A&M 
University, College Station  TX. All calves were tested negative for Salmonella 
spp. as determined by standard fecal culture using enrichment in tetrathionate 
broth (Difco, Detroit, MI). Calves were fed milk replacer twice a day, water ad 
libitum, and fasted 24 hours prior to experimental surgeries. The ligated ileal loop 
surgical procedure was employed as previously described (164, 166). Briefly, 
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anesthesia was induced with propofol (Abbot Laboratories, Chigaco, IL) followed 
by placement of endotracheal tube and maintenance with isofluorane (Abbot 
Laboratories, Chigaco, IL) for the duration of the experiment. A laparotomy was 
performed, the ileum and distal jejunum were exposed and 16-20 loops, 5 to 8 
cm long, were ligated in the ileum and distal jejunum, intercalated with 1-2 cm 
loops. The loops were injected with 3 ml of either sterile LB broth (control loops) 
or LB containing approximately 0.75 x 109 colony-forming units (cfu) of WT S. 
typhimurium. Loops were replaced into the abdominal cavity and excised at 1, 4, 
8, and 12 hours post-infection (HPI). Samples for microarray analysis and 
quantitative Real-Time PCR (qRTPCR) were collected immediately after loop 
excision. The microarray data from BLAD were analyzed and compared to the 
data obtained similarly from four, male, 3-6 week old, Holstein calves negative for 
the BLAD defect (CD18 +/+) submitted to identical experimental protocols 
(hereafter Control).  
 
 
RNA extraction and isolation  
 
 
As the source of host RNA for the microarray analysis and 
qRTPCR, six to eight 6 mm biopsy punches were taken from the intestinal wall 
including mucosa, submucosa, and Peyers patches. Punches were immediately 
cleaned to remove debris, minced into small pieces with a sterile scalpel or razor 
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blade, immersed in 500 µl of TRI-reagent® at 4oC (Ambion, Foster City, CA) and 
further homogenized using a tissue grinder. The RNA was extracted according to 
TRI-reagent manufacturer instructions, the pellet was re-suspended in nuclease-
free water (Ambion, Foster City, CA), and any contaminating DNA was removed 
by RNase-free DNase I treatment (Ambion, Foster City, CA) according to 
manufacturers instructions. Samples were stored at -80oC until used. The 
resultant DNA-free RNA was quantified using a NanoDrop® ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE), and assessment 
of RNA quality was determined using an Agilent 2100 Bioanalyser (Agilent 
Technologies, Santa Clara, CA).  
 
 
Preparation of bovine reference RNA 
 
 
Total RNA was isolated from Madin-Darby bovine kidney (MDBK) and 
bovine B lymphocyte (BL-3) cell lines (American Type Culture Collection, 
Manassas, VA) as well as from the cerebral cortex and cerebellum collected from 
control surgery calves immediately after surgery following euthanasia.  Cell lines 
were grown in 150 cm2 cell culture flasks with Eagles minimum essential 
medium (E-MEM) (ATCC) supplemented with 10% HI-FBS. The cerebral and 
cerebellar tissues were immediately homogenized in 4oC Tri-reagent® (Ambion, 
Austin, TX), the RNA was extracted, and any contaminting DNA was removed as 
  
82
previously described under RNA extraction and isolation. RNA concentration and 
quality from each sample were determined using a NanoDrop® ND-1000 
spectrophotometer and an Agilent 2100 Bioanalyser respectively, before and 
after pooling the samples. Total RNA isolated from three samples was pooled 
together in equal amounts, aliquoted, and stored at -80ºC until used.  
 
 
Construction of bovine cDNA microarrays and annotation 
 
 
Selected unique 70-mers oligonucleotide set representing 13,257 
cattle open reading frames (ORFs) were obtained from normalized and 
subtracted cattle placenta and spleen cDNA libraries based upon the earlier 
bovine cDNA array platform GPL2864 (46) and subtracted cDNA libraries 
created from embryonic (day 36 and day 64) and extra-embryonic (day 14 to 25) 
tissues (NCBI libraries 15993, 15993, and 17188). Positive controls included the 
genes β-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
and hypoxanthine phosphoribosyltransferase (HPRT). Exogenous spiking 
controls included the soybean genes chlorophyll a-b binding protein (CAB), 
rubisco small chain 1 (RBS1), and major latex protein (MSG). Negative controls 
consisted of Cot1 DNA, genomic DNA, spotting buffer, poly-A oligonucleotides, 
and water. All 70-mer oligos were printed in duplicates on aminosilane-coated 
glass slides in 150 mM phosphate buffer at 20 uM concentration, at the W. M. 
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Keck Center (University of Illinois at Urbana-Champaign). The oligos were 
annotated based on the most currently available GenBank accession number. 
 
 
Microarray sample preparation and slide hybridization 
 
 
The washing, labeling, and hybridization procedures were 
performed as previously described (46). In summary, RNA-derived cDNA from all 
seven calf experimental samples (three BLAD and four control calves), including 
infected and control uninfected loops (LB broth), were co-hybridized against 
cDNA generated from the bovine reference RNA sample followed by 
hybridization to the previously described custom 13K bovine ESTs, 70mer, 
oligoarray. High quality RNA derived from all experimental loops was reverse 
transcribed to cDNA using Superscript III reverse transcriptase (Invitrogen, 
Carlsbad, CA) and labeled with amino-allyl-UTP (Ambion, Austin, TX). Cy3 and 
Cy5 dye esters were covalently linked to the amino-allyl group by incubating the 
resultant amino-allyl-labeled cDNA with the dye esters in 0.1M sodium carbonate 
buffer. Prior to hybridization, the microarrays were denatured by boiling, UV 
cross-linked, and immersed in prehybridization buffer [5X sodium chloride, 
sodium citrate buffer (SSC), 0.1% sodium dodecyl sulfate (SDS) (Ambion, Austin, 
TX) and 1% bovine serum albumin (BSA)] at 42ºC for a minimum of 45 min 
followed by four washes in RNase-, DNase-free, distilled water; immersed in 
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100% isopropanol for 10 seconds, and dried by centrifugation. Slides were 
hybridized at 42ºC for approximately 40 hours in a dark humid chamber (Corning, 
Corning, NY) and washed for 5-10 min at 42ºC with low stringency buffer [1 X 
SSC, 0.2% SDS] followed by two 5-10 min washes in a higher stringency buffer 
[0.1 X SSC, 0.2% SDS and 0.1 X SSC] at room temperature with agitation. 
 
 
Acquisition and analysis of microarray data 
 
 
Immediately after hybridization and washing, the slides were 
scanned using a commercial laser scanner (GenePix 4100; Axon Instruments 
Inc., Foster City, CA). The spots representing genes on the arrays were adjusted 
for background and normalized to internal controls using image analysis software 
(GenePixPro 4.0; Axon Instruments Inc.). Spots with fluorescent signal values 
below background were disregarded in all analyses. All host signals were 
normalized against bovine reference RNA signals. The resulting data were 
analyzed using Seralogixs suite of gene expression analysis and modeling 
tools (www.seralogix.com). Genes were designated to have significant differential 
expression (up- or down-regulation) based on Seralogixs Bayesian z-score 
method. In this method, genes are ranked and ordered according to their 
expression magnitudes. In addition, gene variance is computed using a Bayesian 
predicted variance value. The Bayesian variance is determined by using a sliding 
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window algorithm that averages 50 variances directly on the ascending and 
descending ordered sides of each gene of interest. This method is used to 
smooth the variances across the dynamic range of intensity values. Genes with 
statistically significant differential expression were determined with the Bayesian 
z-test (p ≤ 0.025). Identification of Biosignature Dynamic Bayesian Network 
(DBN) modeling, mechanistic gene discovery, and pattern and pathways of 
recognition were determined by advanced computational tools developed by 
Seralogix. Biosignature Analysis Framework developed by Seralogix is 
comprised of an integrated suite of software tools (XManager, XConsole & 
XBuilder) and relational database storage specialized for management and 
analysis of biosignature data. The Seralogix analysis defines mechanistic as 
the genes responsible for the temporal pattern within their DBN models. In other 
words, they are the principal genes that have the most influence in making the 
DBN of a certain condition, in this case BLAD, different from control conditions 
(control). Our analysis focused primarily in the mechanistic genes differentially 
expressed in samples from WT-infected BLAD versus WT-infected control calves  
(Appendix C) and less on the individual genes identified in WT-infected control 
animals versus uninfected samples (LB broth) from the same animals (Appendix 
A) or WT-infected BLAD animals versus uninfected samples (LB broth) from the 
same animals (Appendix B). 
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Validation of microarray results 
 
 
Four randomly selected bovine genes with differential expression 
on microarray analysis common to both BLAD and control animals were 
analyzed by qRTPCR. Quantitative gene expression was determined using an 
Applied Biosystems 5700 DNA Sequence detection system (Applied Biosystems, 
Foster City, CA). RNA from all experimental loops was reverse transcribed to 
cDNA by adding 2 µg of total RNA to a 100 µl reaction containing 2.5 µM of 
random hexamers and reagents from the reverse transcription kit (Applied 
Biosystems, Foster City, CA). The thermal cycle parameters used for reverse 
transcription were 10 minutes at 25oC, followed by 30 min at 48oC, and finalizing 
with 5 min at 95oC. The final working solution of cDNA was diluted to generate 
the concentration of 2 ηg per 10 µl sample. Diluted cDNAs were stored at -80°C 
until used. qRTPCR was performed with SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA). All primers were designed by Primer Express 
Software (Applied Biosystems, Foster City, CA) and synthesized by Sigma-
Genosys (The Woodlands, TX). The list of primers used in this study is provided 
in Table 3.  
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Analysis of qRTPCR data  
 
 
Analysis of the qRTPCR data was performed with the 2-∆∆Ct 
method as previously described (108). The gene GAPDH was used as the 
control housekeeping gene.  According to the 2-∆∆Ct method, the cycle number 
was determined as the cycle at which fluorescence crossed a threshold above 
background (Ct). The resulting Ct value was recorded for each sample for genes 
of interest. The Delta Ct value (∆Ct) for each gene of interest was obtained by 
subtracting their Ct value from their respective housekeeping gene Ct value 
(GAPDH). This was followed by determination of the ∆∆Ct by subtracting the 
resultant ∆Ct for the control samples from the ∆Ct obtained for the infected 
samples. The gene expression fold change in infected tissues compared to 
uninfected control was calculated by converting ∆∆Ct into 2-∆∆Ct. A negative 
control (water) and an RNA sample without reverse transcriptase to determine 
genomic DNA contamination were included as controls during cDNA quantization 
for each primer pair used. Since the Seralogix microarray analysis considered 
genes differentially expressed based on a z-score and not on a fold-change, the 
microarray data were considered valid if the fold change of each gene tested by 
qRTPCR was expressed in the same direction, i.e. up or down-regulated, as 
determined by the microarray analysis. 
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Table 3- Primer sequences used in qRTPCR to study the gene expression of S. 
typhimurium-infected bovine ileal loops. 
GenBank 
accession # 
Gene 
symbol 
Gene name Primer sequencea 
BM_001034034 GAPDH Glyceraldehide-3-
phosphate 
dehydrogenase 
TTCTGGCAAAGTGGACATCGT 
GCCTTGACTGTGCCGTTGA 
NM_001001175 Apoc3 Apolipoprotein C3 GCACCAAGACCGCCAA 
GCAGATTCCCAGAAGTCAGTGAA 
NM_182786 FOS v-fos FBJ murine 
osteosarcoma viral 
oncogene homolog 
ATCTGCTGAAGGAGAAGGAAAAAC 
TGAGGAGTGGCAGGGTGAAG 
NM_174147 PLAU plasminogen activator, 
urokinase 
TGAACGGAGGAAAATGTGTAACC 
TCAGAAGGACGGTGGGAGAG 
NM_174576 PIK3R2 phosphoinositide-3-
kinase, regulatory 
subunit 2 (p85 beta) 
GCTCCTCTACCCAGTGTCCAAGT 
ACGCTGTCCTCCTTGACGAT 
 
aSequences for bovine genes were obtained from GenBank. Top row represents forward primers 
and bottom row shows reverse primers. 
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Results 
 
 
Transcriptional profile of bovine host intestinal loops inoculated with S. 
Typhimurium 
 
 
The general host gene expression response  
 
 
Samples of distal small intestine (ileum and distal jejunum) 
including Peyers patches inoculated with LB broth (uninfected loops) and S. 
typhimurium (WT), from three distinct BLAD (CD18 -/-) and four distinct control 
calves (CD18 +/+) collected a 1, 4, 8 and 12 HPI (n = 56) were used as the 
source of host RNA for the microarray analysis and qRTPCR for validation of 
microarray data. The RNA was indirectly labeled and co-hybridized against 
bovine reference RNA on a custom 13K bovine-specific oligoarray. Experimental 
RNA samples of adequate quality from BLAD and control animals were selected 
based on the following bioanalyzer parameters: RNA integrity number (RIN) > 5.0 
and 28S/18S ratio > 1.1. The bioanalyzer parameters for the reference RNA were 
RIN = 9.7 and 28S/18S ratio = 2.1. The percentage of microarray spots having a 
signal to noise ratio (SNR) higher than three above background  (SNR > 3) was 
variable among arrays. A minimum of 40%, 60%, and 46% of spots had a SNR > 
3 in experimental samples (Cy3 channel; laser excitation = 532), reference 
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samples (Cy5 channel; laser excitation = 635), and combined samples (Cy3-Cy5 
channels), respectively. 
The number of genes identified as differentially expressed (z-score 
p ≤ 0.025) by the microarray analysis varied substantially between the two 
distinct treatment groups used, i.e. BLAD and control calves (Table 4). When 
compared to uninfected loops (LB broth), samples from BLAD calves inoculated 
with WT S. typhimurium had a total of 1,504 uniquely differentially expressed 
genes compared to 673 uniquely differentially expressed genes detected in S. 
typhimurium-infected samples from control calves (p ≤ 0.025) (Table 4). Analysis 
of significant gene expression across all time points taking in consideration 
identical genes expressed at more than one time point revealed that 83.71% of 
the total gene appearances had up-regulation in BLAD contrasted with 74.32% of 
up-regulation appearances in control calves (Table 4). The temporal pattern of 
gene expression had remarkable differences. While the peak of gene expression 
in BLAD calves occurred at 4 HPI followed by a progressive reduction in the 
number of differentially expressed genes on late time points, control calves had 
an earlier peak of gene expression at 1 HPI followed by a marked reduction at 
4HPI and de novo high expression profiles at 8 and 12 HPI (Figure 16). 
 
 
 
 
 
  
91
Table 4- Summary of differentially expressed genes at each time point in S. 
typhimurium-infected bovine ligated ileal loops from BLAD and control calves 
compared to uninfected control loops (LB broth). 
Condition Total genes changeda Total up and down-regulatedb Time post-inoculation 
   1 4 8 12 
BLAD 1445 43 740 375 287 
 
1504 
222 21 19 22 160 
Control 660 168 43 220 229 
 
673 
228 136 7 30 55 
Genes common across the 2 conditions 11 9 30 80 
aTotal genes with significantly different expression reflect the total number of genes that were 
uniquely expressed across all time points without taking into consideration expression of a gene 
in more than one time point. 
bFor each treatment group, the top row represents significantly up-regulated genes and the 
bottom row denotes the significantly down-regulated genes (p ≤ 0.025).  Total numbers of up or 
down-regulated genes include identical genes expressed at more than one time point. 
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Figure 16: Temporal profile of differentially expressed genes  (p ≤ 0.025) in S. 
typhimurium-infected bovine ligated ileal loops from BLAD (A) and control calves  
(B) compared to uninfected control loop (LB broth). 
 
 
The Seralogix statistical methods used in the analysis of our 
microarray data identified the most significantly activated pathways across all 
time points ranked by z-score. The list of the top 20 scoring pathways identified 
for S. typhimurium-infected BLAD and control calves compared to loops of 
uninfected control calves (LB broth) had striking differences between the two 
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treatment groups (Table 5). While some of most studied pathways in Salmonella 
infections including regulation of actin cytoskeleton (73, 145, 156), Toll-like 
receptor (TLR) signaling pathway (37, 64), and apoptosis (72, 103), were among 
the top activated in Control, the list of top scoring pathways in BLAD was 
dominated by a vast majority of genes associated with metabolic pathways 
important for normal cell metabolism (Table 5). 
 
 
Table 5- Top 20 scoring cellular pathways activated in S. typhimurium-infected 
bovine ligated ileal loops from BLAD and control calves compared to uninfected 
control loops (LB broth). 
a Pathways listed from the highest to the lowest z-score value. 
 
Ranka CONTROL (CD18 +/+) BLAD (CD18 -/-) 
1 Oxidative phosphorylation Cyanoamino acid metabolism 
2 Cytokine-cytokine receptor interaction Cysteine metabolism 
3 Toll-like receptor signaling pathway Taurine and hypotaurine metabolism 
4 MAPK signaling pathway Maturity onset diabetes of the young 
5 Apoptosis Ethylbenzene degradation 
6 Jak-STAT signaling pathway Alkaloid biosynthesis I 
7 Leukocyte transendothelial migration CD40L Signaling Pathway 
8 Epithelial cell signaling in Helicobacter 
pylori infection 
Glycolysis / Gluconeogenesis 
9 Propanoate metabolism Stilbene, coumarine and lignin biosynthesis 
10 Type I diabetes mellitus Urea cycle and metabolism of amino 
groups 
11 Natural killer cell mediated cytotoxicity Linoleic acid metabolism 
12 Dichlorobenzoate degradation Reductive carboxylate cycle (CO2 fixation) 
13 Long-term depression Phenylalanine, tyrosine and tryptophan 
biosynthesis 
14 Citrate cycle (TCA cycle) C21-Steroid hormone metabolism 
15 Cysteine metabolism Gamma-Hexachlorocyclohexane 
degradation 
16 T cell receptor signaling pathway Biotin metabolism 
17 TGF-beta signaling pathway Prion disease 
18 Gap junction Lysine biosynthesis 
19 Long-term potentiation Glycosylphosphatidylinositol (GPI)-anchor 
biosynthesis 
20 Regulation of actin cytoskeleton Porphyrin and chlorophyll metabolism 
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Inflammation and immune response 
 
 
Comparative analysis of the global gene expression between BLAD 
and control treatment groups at the first stages of acute infection revealed 
evidence of an early activation of inflammatory response in control animals. At 1 
and 4 HPI, samples from control but not from BLAD calves (Appendices A & B) 
had up-regulation of the major pro-inflammatory gene PTGS2 (prostaglandin-
endoperoxide synthase 2). The protein encoded by this gene, also known as 
Cyclooxygenase-2, is a key enzyme in prostanoid biosynthesis and generation of 
other mediators that initiate inflammation (93). Regardless of this strong evidence 
of early inflammatory signaling initiation in control animals, our data provided 
evidence that endothelial transmigration of leukocytes was possibly impaired at 
the earliest stage of infection (1 HPI) in BLAD animals since our analysis 
revealed that down-regulation of the mechanistic gene ICAM1 (intercellular 
adhesion molecule-1) (Appendix C) and down-regulation of VCAM (vascular 
adhesion molecule) (Appendices A & B) in samples from control when compared 
to those from BLAD calves. The proteins encoded by these two genes are 
endothelial adhesion molecules activated during leukocyte transmigration in 
acute inflammation and are required for extravasation of leukocytes into the 
surrounding tissue (28). In addition to inflammation, the cell mediated immune 
response at 1 HPI showed evidence of impairment in samples from control 
compared to those from BLAD animals, characterized by down-regulation of the 
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genes BoLA-DRB3 (major histocompatibility complex, class II, beta chain) and 
CD3D (CD3d molecule, delta) (Appendices A & B). The protein encoded by 
BoLA-DRB3 (MHC class II) is required for presentation of intracellularly 
processed antigens to CD4+ helper T cells during induction of cellular immunity 
(116). The CD3D gene encodes a structural component that forms part of the 
CD3 molecule, a T-cell receptor (TCR) accessory protein (126). TCRs are 
transmembrane proteins expressed in lymphocytes that recognize and bind to 
MHC-presented antigens during activation of the cellular immune response 
(126). Also at 1 HPI, samples from control but not from BLAD calves had down-
regulation of the gene CD79a (Appendices A & B). This gene encodes a 
structural component of the B-cell receptor (BCR), which generates signals that 
mediate the humoral immune response triggered by antigen recognition (13).  
 
 
Toll-like receptor signaling pathway 
 
 
Unlike the earliest stage of acute infection at 1 HPI, our data 
showed that the majority of inflammation-associated genes were differentially 
expressed beginning at 4 HPI. Perhaps, the most important of these genes when 
considering the current literature relevant to salmonellosis are those encoding 
TLRs. The most studied TLRs in Salmonella infections are TLR2, TLR4, and 
TLR5, which are activated by bacterial lipoproteins, lipopolysaccharide (LPS), 
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and flagellin, respectively (64). TLR4 signaling in mice plays a important role in 
the host defense against Salmonella infection by controlling the bacterial loads in 
mesenteric lymph nodes (208). Infection of human macrophages by S. 
typhimurium activates TLR4 resulting in CXC chemokine production, which is the 
triggering factor leading to the massive tissue influx of neutrophils characteristic 
of non-typhoidal salmonellosis (141, 155). Our data demonstrated up-regulation 
of TLR4 in both treatment  groups and this expression coincided with the peak of 
gene expression in BLAD calves at 4 HPI and the two late peaks of gene 
expression in control calves at 8 and 12 HPI (Appendices A and B). This up-
regulation of TLR4 in the late stages of acute infection in control was also 
supported in our analysis by late up-regulation of other directly related 
downstream genes as part of the TLR4-signaling pathway including NFKBIA and 
FOS (Appendix A). Although significant up-regulation of TLR4 was not observed 
after 4 HPI in BLAD calves, our data showed significant up-regulation of NFKBIA 
and FOS at the later time points at 8 and 12 HPI (Appendix B), indicating that 
TLR signaling pathway maintains an activated state in BLAD calves in the later 
stages of acute response and that this activation may be independent of TLR4 
activation.  
In addition to TLR-associated genes, other inflammatory genes 
were consistently up-regulated in samples from control animals at or after 4 HPI 
including SELP (P-selectin) and Cebpd (CCAAT/enhancer binding protein) 
(Appendix A), as well as the two mechanistic genes ICAM-1 and TNFRSF1A 
(tumor necrosis factor receptor superfamily, member 1A) (Appendix C). Similarly 
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to ICAM-1 and VCAM, P-selectin is an endothelial adhesion molecule that 
facilitates endothelial transmigration of leukocytes during acute inflammation 
(28). The gene Cebpd encodes a transcription factor that results in production of 
pro-inflammatory mediators by possibly activating COX-2 transcription (27) and 
TNFRSF1A encodes an extracellular domain of the TNF receptor (153). The TNF 
receptor is commonly activated during inflammatory conditions and is important 
to orchestrate an adequate cellular response (153). None of these inflammation-
associated genes were up-regulated in samples from BLAD animals at any time 
point (Appendices B and C). 
 
 
Cytokine profile 
 
 
The profile of cytokine activation during Salmonella-induced 
enteritis has been extensively investigated; however, the global gene expression 
profile in S. typhimurium-infected intestine using an in vivo model of non-
typhoidal salmonellosis has not been characterized (41). Our mechanistic gene 
data comparing WT-infected samples from BLAD versus control calves had 
consistent up-regulation of typical Salmonella-infection associated pro-
inflammatory cytokine genes such as IL-1β and IL-6 across all time points in 
control animals (Appendix C). Interestingly, BLAD animals also had a similar 
temporal pattern of pro-inflammatory cytokine gene expression beginning at 4 
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HPI with up-regulation of the cytokine genes IL-1β and IL-6 (Appendix C). 
Cytokine genes whose products exhibit primary chemotactic activity for 
monocytes but not for neutrophils such as the chemokine genes CCL2 (encodes 
monocyte chemoattractant protein-1/MCP-1) and CCL8  (encodes monocyte 
chemoattractant protein 2/MCP-2) (12) were persistently up-regulated across all 
time points in control calves (Appendix C).  These chemokine genes were 
generally up-regulated in BLAD animals as well except at 8 HPI, when both 
genes were down-regulated (Appendix C). 
 
 
Apoptosis 
 
 
Induction of apoptosis has been previously implicated in the 
pathogenesis of Salmonella infections (82, 103).  The global expression of 
apoptosis-associated genes in our samples had distinct gene expression profiles 
in control as compared to BLAD animals. While the results of gene expression in 
samples from control calves had a final balance between pro- and anti-apoptotic 
stimuli, the few apoptosis-associated genes differentially expressed in samples 
from BLAD animals were dominated by pro-apoptotic stimuli (Table 6). 
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Table 6- Apoptosis-associated genes differentially expressed in S. typhimurium-
infected bovine ligated ileal loops from BLAD and Control calves compared to 
uninfected control loop (LB broth). 
Condition Symbol Gene Name Expressiona Function Ref. 
AKT1 v-akt murine thymoma viral 
oncogene homolog 1 
Down anti-apoptotic (19) 
MGC133975 similar to BCL2/adenovirus 
E1B 19kD interacting 
protein 1 isoform BNIP1-c 
Down anti-apoptotic (140) 
cFLAR CASP8 and FADD-like 
apoptosis regulator 
Up anti-apoptotic (173) 
BCL2A1 BCL2-related protein A1 Up anti-apoptotic (209) 
MGC139459 similar to RTP801 Up anti-apoptotic (170) 
LOC512355 similar to TNF receptor-
associated factor 2 
Up anti-apoptotic (104) 
LOC522886 similar to periplakin Up anti-apoptotic (194) 
CASP4 caspase 4 Up pro-apoptotic (204) 
Control 
LOC517192 similar to jun D proto-
oncogene 
Up pro-apoptotic (83) 
AKT1 v-akt murine thymoma viral 
oncogene homolog 1 
Up anti-apoptotic (19) 
MGC133975 similar to BCL2/adenovirus 
E1B 19kD interacting 
protein 1 isoform BNIP1-c 
Up anti-apoptotic (140) 
BLAD 
CASP6 Caspase 6 Down Pro-apoptotic (209) 
a
Gene expression was variable among distinct time points but with no preference for any time point. 
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Intracellular defense against infection 
 
 
Phagocytic cells play a crucial role in host resistance to Salmonella 
following intestinal invasion (50, 198, 199). Immediately following phagocytosis, 
the intracellular NADPH oxidase system in phagocytes produces highly toxic 
reactive oxygen and nitrogen species (ROS and NOS) that control infection by 
promoting Salmonella killing (198). Although essential for intracellular defense 
against Salmonella, elevated levels of ROS AND NOS can cause severe 
damage to DNA, protein, and lipids in phagocytes, as well as necrosis of 
surrounding tissue as a result of leakage during phagocytosis (16, 151). 
However, cells have evoked mechanisms of defense against oxidative and 
nitrosative damage represented by the antioxidants (115). Analysis of 
differentially expressed genes associated with the intracellular oxidative and 
nitrosative systems in our samples from control animals had predominantly up-
regulation of antioxidant genes including SOD2 (superoxide dismutase 2) 
(Appendixes A and C), TXNRD1 (thioredoxin reductase), and ARG2 (arginase, 
type II) (Appendix A). The gene SOD2, whose product is important to protect 
macrophages from oxidative stress during microbial infections (151), was up-
regulated at all time points with progressively higher fold change towards later 
time points reaching up to 15 fold-change compared to uninfected samples (LB 
broth) at 12 HPI (data not shown). 
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 The genes TXNRD1 and ARG2 were both up-regulated in the late 
stages of acute infection (Appendix A). TXNRD1 encodes a oxidoreductase that 
protects against oxidative stress especially in vascular endothelial cells (186) and 
the product of gene ARG2 has been shown to play an important role in limiting 
nitric oxide production in bovine (29). In samples from BLAD calves, three genes 
associated with the oxidase and nitrosative systems were identified with SOD2 
being the only gene in common with samples from control animals. Besides 
SOD2, a second antioxidant-associated gene, NQO1 (NAD(P)H dehydrogenase, 
quinone 1) was up-regulated (Appendixes B and C). Up-regulation of SOD2 was 
observed at 4 and 12 HPI with a lower fold-change increase compared to control 
animals (data not shown) while up-regulation of NQO1 was observed at 4 and 8 
HPI. The product of NQO1 is a cytoprotective enzyme that promotes 
detoxification of ROS (9). The third and last gene, CYP11A1, encodes a member 
of the cytochrome P450 family (cytochrome P450, family 11, subfamily A, 
polypeptide 1) which was up-regulated at 4 HPI (Appendix B). The cytochrome 
P450 proteins are monooxygenases, which catalyze many reactions involved in 
drug metabolism and synthesis of cholesterol, but also are well-known sources of 
mitochondrial ROS production (38). In addition, BLAD but not control animals, 
had down-regulation of the anti-inflammatory interleukin-10 gene (IL10) at 12 HPI 
(Appendix B).  
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IL-10 exerts its anti-inflammatory properties by down-regulating 
neutrophil functions, especially reactive oxygen species (ROS) production via 
NADPH oxidase (35). Collectively, the data from BLAD animals indicate a 
balance between genes involved in production of ROS and NOS potentially 
deleterious to the host and genes with anti-oxidant protective functions.  
 
 
Validation of microarray gene expression results by qRTPCR 
 
 
The cDNA used on qRTPCR to validate the microarray results was 
synthesized from the same RNA samples used for microarray hybridization. 
Analysis of gene expression in all tested genes at all time points had fold 
changes altered in the same direction in microarray and qRTPCR analyses in 
samples from both BLAD (Fig. 17) and control calves (Fig. 18). 
 
 
 
 
  
103
A
-13
-11
-9
-7
-5
-3
-1
1
1h 4h 8h 12h
Time post-inoculation (hours)
qRTPCR
Microarray
B
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
1h 4h 8h 12h
Time post-inoculation (hours)
qRTPCR
Microarray
  
C
0
1
2
3
4
5
6
7
1h 4h 8h 12h
Time post-inoculation
qRTPCR
Microarray
D
0
2
4
6
8
10
12
1h 4h 8h 12h
Time post-inoculation
qRTPCR
Microarray
 
Figure 17: Validation of bovine microarray results by qRTPCR in samples from 
BLAD calves. Four randomly selected genes are depicted that were differentially 
expressed as revealed by microarray analysis of S. typhimurium-infected bovine 
ligated ileal loops compared to uninfected control loops (LB broth). A = 
Apolipoprotein C3 (Apoc3); B = phosphoinositide-3-kinase, regulatory subunit 2 
(PIK3R2); C = Plasminogen, urokinase (Plau); D = v-fos FBJ murine 
osteosarcoma viral oncogene homolog (FOS). 
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Figure 18: Validation of bovine microarray results by qRTPCR in samples from 
control calves. Four randomly selected genes are depicted that were differentially 
expressed as revealed by microarray analysis of S. typhimurium-infected bovine 
ligated ileal loops compared to uninfected control loops (LB broth). A = 
Apolipoprotein C3 (Apoc3); B = phosphoinositide-3-kinase, regulatory subunit 2 
(PIK3R2); C = Plasminogen, urokinase (Plau); D = v-fos FBJ murine 
osteosarcoma viral oncogene homolog (FOS). 
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Discussion 
 
 
A massive tissue influx of neutrophils is the hallmark of S. 
typhimurium-induced enteritis and diarrhea in humans and in the bovine model of 
non-typhoidal salmonellosis (190).  The objective of this study was to identify the 
influence of the neutrophilic inflammation during the temporal global gene 
expression profiles after intestinal infection by S. typhimurium. For this purpose, 
we employed microarray technology in the well-accepted bovine ligated ileal loop 
model in calves with confirmed genetic deficiency of neutrophil extravasation, i.e. 
CD18 -/-, BLAD calves. The Seralogix microarray analysis performed on data 
from BLAD samples were compared to the results from control animals (CD18 
+/+) submitted to similar experimental protocols. The current availability of 
bovine-specific microarrays introduced a new and powerful method capable of 
significantly raising our understanding on disease pathogenesis in cattle, which 
was previously limited by the lack of availability of tools to analyze both the host 
and pathogen responses (212). In addition, DNA microarray analysis of host 
gene expression allows fundamental questions to be addressed about the basis 
of host defense and microbial virulence (113), and perhaps most importantly, 
identification of potential biomarkers that could be used for future therapeutic 
purposes (69). 
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Analysis of the general picture obtained from the Seralogix 
analysis of microarray data identified remarkable differences in gene expression 
between the two animal treatment groups.  The marked contrast between total 
number of uniquely expressed genes in BLAD versus control (1,504 vs. 673) 
confirmed that the neutrophilic inflammation greatly influences the host gene 
expression; therefore, suggesting that tissue influx of neutrophils largely dictates 
the genetic host response. More importantly, our data also revealed that the 
temporal gene expression during the acute host response to infection is also 
markedly altered by the neutrophilic influx. While infection in control animals 
resulted in a initial peak of gene expression (1 HPI) followed by a short silent 
period (4 HPI) that preceded a return of gene expression peaks (8 and12 HPI), 
the BLAD data indicated a reduced initial activation of gene expression followed 
by a later peak at 4 HPI and a progressive decrease during the late stages of 
acute infection (8 and 12 HPI). These data suggest that the influence of 
neutrophil influx over the host gene expression begins as early as 1 HPI, despite 
the fact that influx of neutrophils at that stage is still mild (164).  
The period of silent gene expression in control animals coinciding 
with the peak gene expression in BLAD animals at 4 HPI suggests that the 
marked influx of neutrophils observed in infected genetically normal calves at this 
stage (161, 164), prevent bacteria from triggering massive gene expression as 
seen in BLAD calves. Previous studies have shown that number of invading 
bacteria in the intestinal mucosa do not reduce over time during this stage of 
enteritis in calves (223); therefore, it is unlikely that neutrophils prevent this peak 
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of Salmonella-induced host gene expression by controlling the tissue burden of 
bacteria. An alternative explanation suggested by our data is that phagocytosis of 
significant numbers of Salmonella by infiltrating neutrophils may prevent bacterial 
activation of gene expression in other host cells such as epithelial cells and 
macrophages, which are known to play major roles in gene activation during 
infection (51, 158). Significant phagocytosis of S. typhimurium by neutrophils 
during this stage of infection has been previously documented by electron 
microscopy studies (164). 
The importance of neutrophils in the pathogenesis of host gene 
activation is emphasized in our data by the marked differences between top-
scoring pathways activated throughout the course of infection between control 
and BLAD animals.  The vast majority of top scoring pathways observed in 
control animals came as no surprise since they indeed represent the major fields 
of study in Salmonella research. The current data available on most of these 
pathways, which are mainly represented by inflammatory and immune response 
as well as cell signaling, have been the focus of numerous literature reviews (21, 
31, 149, 177). Although most of these top-scoring pathways from control animals 
were also represented to some degree in BLAD calf samples, the statistical 
methods used by the Seralogix analysis identified the majority were other top 
scoring unrelated metabolic pathways in BLAD calves, reinforcing the concept 
that infiltrating neutrophils during Salmonella-induced enteritis results in direct 
and indirect manipulation of the host genetic expression machinery. 
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The inflammatory lesions that characterize Salmonella enteritis 
result from the triggering of host innate immune responses by the invading 
pathogen (177). The literature available to date suggests that neutrophilic 
inflammation in non-typhoidal salmonellosis is likely triggered by the combination 
of two main events, which are direct activation of pro-inflammatory cytokine 
genes in the host by effectors proteins secreted by the Salmonella pathogenicity 
island-1 (SPI-1) encoded Type 3 Secretion system (TTSS-1); and indirect 
activation of innate pathways of inflammation through activation of the pathogen 
recognition receptor TLR5 by biding of Salmonella-produced and secreted  
flagellin, which is a type of pathogen-associated molecular pattern (PAMP)  (79, 
190). It is important to note; however, that while the vast majority of evidence 
supporting the direct activation hypothesis described above are based on in vivo 
models of non-typhoidal salmonellosis such as the bovine (8, 187, 188, 203, 206, 
223) and the streptomycin pretreated mice (14, 76), evidence supporting the 
indirect activation hypothesis via TLR5 is based entirely on in vitro studies using 
human epithelial cells lines, particularly the colonic cell line T84 (65, 66, 88, 179, 
183, 220). The microarray data in control animals confirmed the in vivo activation 
of the TLR system (TLR4) and downstream genes associated with the TLR 
pathway (NFKBIA & FOS) beginning at 4 HPI; however, this activation was not 
detected in the earliest stage of infection at 1 HPI. Since our data in samples 
from control animals had evidence of inflammatory gene activation at this time 
point (PTGS2) in the absence of significant TLR gene activation, we suggest that 
the first morphologic signs of mild neutrophilic inflammation observed in infected 
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genetically normal calves at 1 HPI is mediated by a TLR-independent 
mechanism, i.e. most likely via direct activation of pro-inflammatory cytokines by 
the invading S. typhimurium. Interestingly, data from BLAD calves showed 
activation of the TLR pathway at 4 HPI (TLR4) plus the same related 
downstream genes in later time points (NFKBIA and FOS) agreeing with the data 
in samples from control animals; however, no evidence of inflammatory gene 
activation was detected in BLAD at 1 HPI. Collectively, these observations in 
BLAD and control animals suggest that the activation of the TLR pathway in S. 
typhimurium-induced enteritis is primarily induced by secreted flagellin and 
independent of neutrophilic influx. In contrast, the early inflammatory gene 
activation, which appears to be TLR-independent according to our data, is 
influenced in some manner by the mild tissue influx of neutrophils observed at 
that stage.  
Sequestration and migration of neutrophils in response to acute 
inflammation involve sequential steps, including adhesion and transmigration 
through the vascular wall into interstitial tissues (39). Adhesion and 
transmigration of neutrophils are largely mediated by endothelial adhesions 
molecules of the immunoglobulin superfamily, which bind to various integrins 
present on the leukocyte cell surfaces (152). Data from control animals which 
had down-regulation of major endothelial adhesion molecule genes (ICAM1 & 
VCAM) at 1 HPI may explain the mild neutrophilic enteritis seen in S. 
typhimurium-infected bovine ligated ileal loops in this early stage (164). In 
addition, these data may alternatively suggest that this down-regulation may 
  
110
represent a host mechanism of negative feedback as an attempt to control 
exaggerated extravasation of neutrophils and propagation of inflammation, 
potentially deleterious to the host. The latter suggested hypothesis is also 
supported by our findings that BLAD animals with their characteristic absence of 
neutrophilic inflammation did not have down-regulation of these endothelial 
adhesion molecules at any time point.  
Most studies investigating the host immunity to Salmonella 
infections focus in the innate immune response (innate immunity) (1, 17, 177, 
211) with only a few manuscripts studying the cell and antibody-mediated 
immune responses, i.e. the adaptive or acquired immunity (185, 195). T 
lymphocytes have a central role in controlling and clearing infection by 
intracellular pathogens through cytokine production (195). In order to become 
capable of producing cytokines, T lymphocytes need to be activated by 
interaction with professional antigen-processing cells, typically dendritic cells 
(DCs), that initiate adaptive immunity against bacteria (185). In vivo studies in 
mice infected with S. typhimurium (model of typhoidal salmonellosis) and in vitro 
studies using murine DCs have found that virulent (WT) S. typhimurium prevent 
antigen presentation to T cells, thus escaping acquired immunity suggested to be 
mediated by effector proteins encoded within the Salmonella pathogenicity island 
2 (SPI-2) (185). A recent study suggested that S. typhimurium have a direct, 
contact-dependent inhibitory defect in T cells, even in the absence of DC 
stimulation (195). Although the outcome of S. typhimurium infection in the murine 
model (typhoidal salmonellosis) is distinct from the bovine model (non-typhoidal 
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salmonellosis) (221), our data from samples of control animals provided evidence 
of impaired acquired immune response due to down-regulation of BoLA-DRB3 
(MHC-II, β chain), CD3E, and CD79a at 1 HPI, suggesting that S. typhimurium 
retain their ability to prevent T cell  activation in the bovine model of typhoidal 
salmonellosis. BLAD animals did not have any significant expression of these 
immunity-related genes at the same point (1 HPI). In addition, none of the 
several pro-inflammatory genes identified at later time points in control animals, 
other than the ones associated the TLR-pathway, were differentially expressed in 
BLAD calves, including genes that encode the proteins P-selectin, TNF receptor, 
and COX-2, reinforcing the notion that inflammatory gene activation in BLAD 
were mostly limited to TLR pathway activation. The significance of these findings 
translates into a concept that tissue influx of neutrophils dramatically influences 
and manipulates the host pro-inflammatory gene repertoire, except TLR 
pathway-associated genes, which appear to be essentially under the influence of 
invading Salmonella. 
Maintenance, progression, and propagation of intestinal 
inflammatory changes that follow S. typhimurium invasion is essentially 
orchestrated by the profiles of expression of cytokines and chemokines produced 
by the genes of the host, regardless of whether it was initiated through direct host 
gene activation by bacterial effector proteins and/or indirectly through TLR 
pathway activation (31, 177). Therefore, accurate identification of the pro-
inflammatory cytokine profile genes during infection is critical for understanding 
the pathogenesis of salmonellosis and for future therapeutic interventions. Our 
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microarray data had many similarities of cytokine and chemokine mechanistic 
gene expression profiles between control and BLAD animals. Up-regulation of 
the major pro-inflammatory cytokines genes (IL-1β and IL-6) and chemokine 
genes (CCL2 and CCL8) were detected in both animal treatment groups. The 
cytokine gene expression in BLAD animals was delayed beginning at 4 HPI 
compared to control calves; however, this delay was not observed for 
chemokines. These results suggest that the presence of tissue neutrophils is not 
required for expression of major pro-inflammatory cytokines and chemokines 
throughout most of the course of acute infection, yet tissue neutrophils may act 
as positive regulators of cytokine gene expression in the earliest stage of 
infection (1 HPI), or alternatively, they may actually be a source for the cytokine 
gene expression at this stage. Although the inflammatory infiltrates that 
characterize S. typhimurium-induced enteritis in calves and humans are 
composed primarily of neutrophils (164, 223), our data found that both BLAD and 
control animals have the appropriate stimulus for tissue recruitment of 
macrophages via up-regulation of two major monocyte/macrophage 
chemoattractant genes,  CCL2 and CCL8, which encode MCP-1 and MCP-2 
respectively. It is important to note that BLAD animals in response to intestinal 
bacterial infections typically develop lesions composed predominantly of 
macrophages and fewer lymphocytes and plasma cells, therefore, despite the 
fact all leukocytes express β2 integrins on their surface, these cell types are 
considered to have alternate ways to extravasate and reach the tissue 
extracellular matrix in BLAD calves (5, 98, 197).  
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Induction of apoptosis has been recognized as an important 
mechanism by which Salmonella successfully escape from the host cells and re-
infect new cells propagating the infection (103). Studies on cell lines and murine 
macrophages have shown that the SPI-1 effector SipB activates caspase-1 in 
macrophages, releasing IL-1β and IL-18 and inducing rapid cell death by a 
mechanism that has features of both apoptosis and necrosis (82, 109). In vitro 
experiments using bovine macrophages found that S. typhimurium can induce 
apoptotic cell death by an early sipB-mediated and delayed sipB-independent 
mechanisms (162); however, experiments using in situ detection of apoptosis in 
bovine ligated ileal loops infected by S. typhimurium showed that apoptosis was 
not significant in the early stages of acute infection (163). Compared to 
macrophages, apoptosis in epithelial cells infected by Salmonella appear to be 
delayed or inhibited (103). Data in our samples from control animals had 
differential expression of several genes directly or indirectly associated with the 
apoptotic pathway resulting in a final balance between pro- and anti-apoptotic 
stimuli. In contrast, differential gene expression of apoptosis-associated genes in 
samples from BLAD animals was limited to three genes only, all of which favor 
anti-apoptotic stimuli. Two of these genes, whose products are the anti-apoptotic 
enzyme Akt1 and a protein with functions similar to Bcl-2, were common to both 
animal groups and found to be up-regulated in BLAD and down-regulated in 
control samples. Akt1 is a serine/threonine protein kinase that functions as a 
critical regulator of cell survival by inhibiting apoptosis (175) and members of the 
anti-apoptotic Bcl-2 family function by interacting with and antagonizing pro-
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apoptotic family members (25). These results suggest that intestinal S. 
typhimurium infection per se, i.e. in the absence of significant neutrophilic 
enteritis, induces host gene expression that favors inhibition of apoptosis. In 
addition, based on the data from control animals, it is tempting to speculate that 
infiltrating tissue neutrophils can potentially represent the key event that triggers 
host apoptosis during S. typhimurium induced enteritis. This hypothesis is 
supported by the previous study using S. typhimurium-infected bovine ligated 
ileal loops showing that apoptosis was significantly detected in situ only at the 
last stages of infection when neutrophilic inflammation was severe.  
The importance of phagocytic cells in controlling S. typhimurium 
infection in mice has been characterized in several experiments using the murine 
model of typhoid fever (198). Accordingly, oxidative damage by neutrophils and 
macrophages is essential for resistance against the early phase of infection, 
whereas nitrosative stress secondary to the action of inducible nitric oxide 
synthase (iNOS) plays a role in host resistance in the later phase of infection (36, 
117, 169).  More importantly, oxygen radicals can have pathological effects in 
salmonellosis also have been associated with increased lipid peroxidation and 
cell death of enterocytes in rats (122). Predominant up-regulation of antioxidants 
from control animals (Sod2, TXNR1, & ARG2) suggests that activation of the 
oxidative and nitrosative stress in phagocytic cells during S. typhimurium-induced 
enteritis in calves is highly controlled, therefore, also suggesting that tissue 
damage that accompanies enteritis in this model cannot be attributed mainly to 
the damaging effects of ROS/NOS. Samples from BLAD animals had similar 
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responses, i.e. antioxidant-controlled activation of oxidative and nitrosative 
stress. The only gene associated with oxidative stress common to both animal 
groups was the major antioxidant enzyme gene SOD2, whereas the genes 
TXNRD1 and AGD2 were unique to control animals, while NQO1 and CYP11A1 
genes were unique to BLAD animals. BLAD calves do not typically have 
significant numbers of tissue neutrophils, yet macrophages are able to 
extravasate and infiltrate the adjacent tissue during inflammation.  This 
discrepancy of infiltrating inflammatory cell type and the oxidative stress-
associated gene types between control and BLAD may simply reflect the 
predominance of different cell types in each animal treatment group. Therefore, 
the oxidative genes detected in BLAD calves are most likely derived from 
macrophages, whereas the genes from control animals likely represent a pool 
between a predominance of neutrophils and significantly fewer macrophages.  
In conclusion, S. typhimurium infection of ligated ileal loops in 
calves with Bovine Leukocyte Adhesion Deficiency results in markedly distinct 
global and temporal gene expression profiles compared to the gene expression 
profiles observed in genetically normal calves. Our results confirmed that the 
massive tissue influx of neutrophils, the hallmark of Salmonella-induced enteritis 
in non-typhoidal salmonellosis, is not only a morphologic outcome of infection but 
also greatly influences and regulates the host gene expression profile.  
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Major differences in gene expression on prioritized areas of 
salmonella research including inflammation and immune response, Toll-like 
receptor signaling pathway, cytokine profiles, apoptosis, and intracellular defense 
against infection were detected by microarray analysis and their significance for 
understanding the pathogenesis of salmonellosis is discussed extensively. It is 
important to keep in mind, when analyzing the results present in this work, that 
many differentially expressed genes may partially reflect the gene expression of 
neutrophils especially in the later stages of infection, given the massive number 
of tissue neutrophils present in infected normal calves and absent in BLAD 
calves. Nevertheless, the results produced by these experiments provide 
essentially more detailed information as the basis for new concepts regarding the 
host global gene expression using an in vivo model for the molecular 
pathogenesis of non-typhoidal human salmonellosis. 
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CHAPTER V 
 
 
CONCLUSIONS 
 
 
Massive tissue influx of neutrophils is the hallmark of Salmonella 
typhimurium-induced enteritis in calves and humans. Yet, the in vivo role of 
neutrophils in the pathogenesis of Salmonella-induced enteritis and diarrhea 
remains incompletely understood. The overall goal of this investigation was to 
establish a functional and informative model to evaluate the contribution of 
neutrophils in the molecular pathogenesis of non-typhoidal ruminant and human 
salmonellosis. To accomplish this goal, we employed the ligated ileal loop model 
in calves with the naturally-occurring Bovine Leukocyte Adhesion Deficiency 
(BLAD) mutation. Neutrophils from BLAD calves are unable to extravasate and 
infiltrate the tissue matrix as a normal host response to intestinal infection, 
because these calves carry a genetic mutation in the CD18 molecule of the β2 
integrin family of leukocyte adhesion molecules. 
In Chapter II, a detailed description of the intestinal morphologic 
lesions associated with S. typhimurium infection in BLAD animals was 
accomplished as the basis for comparing our findings with previously published 
studies using genetically normal calves negative for the BLAD mutation. The 
conclusions of our findings was that the massive tissue influx of neutrophils 
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following ileal infection in normal calves is a major contributing factor in 
morphological pathogenesis of the severe pathologic lesions that occur in the 
acute stage of the enteritis, including the massive superficial enteric necrosis. 
Also in the same chapter, infected ileal samples from BLAD calves were 
compared to normal calves and evaluated for fluid accumulation, bacterial 
invasion, and cytokine profiles. Analysis of our data revealed that the tissue influx 
of neutrophils and its accompanying tissue damage is strongly associated with 
the degree of luminal fluid accumulation and diarrhea. These data confirm the 
prevailing hypothesis that the Salmonella-associated diarrhea is primarily caused 
by a exudative inflammatory mechanism due to loss of mucosal integrity rather 
than by secretory mechanisms involving chloride secretion. We also found that 
the presence of tissue neutrophils also aid in the control of bacterial invasion, 
providing evidence that not only macrophages but also infiltrating neutrophils 
phagocytose and eliminate invading bacteria as part of the first line of host 
defense. Analysis of our cytokine profile data clearly demonstrated that the 
massive influx of neutrophils in the acute infection, especially at the late phase, is 
mainly driven by the chemokine GRO-α and to a lesser extent by IL-8. We also 
found the IL-8 can be highly expressed in the absence of neutrophil influx 
suggesting that infiltrating neutrophils are not significant sources of IL-8 gene 
expression. Our data also revealed that the influx of neutrophils likely plays a 
minor role in the expression of the pro-inflammatory cytokines IL-1β and TNF-α, 
although a tendency for lower expression of IL-1β in the absence of tissue 
neutrophils was found. 
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In Chapter III, we applied the Laser Capture Microdissection (LCM) 
technique to analyze BLAD ileal samples to better characterize the in situ 
localization of gene expression of the cytokines investigated in Chapter II. We 
showed that enterocytes of crypts, villi tips, and cells that form the domed villi 
overlying Peyers patches, including the follicle-associated epithelium, are 
important sources of gene expression for IL-8, GRO-α, and IL-1β, but not TNF-α. 
Interestingly, all three detected cytokines were predominantly expressed in 
enterocytes of crypts. Also in the same Chapter, we investigated the pattern of S. 
typhimurium invasion in ileal loops from BLAD animals by using 
immunohistochemistry for Salmonella O antigen.  Our results showed that S. 
typhimurium, in the absence of neutrophil influx, invade the tips of absorptive villi, 
follicle-associated epithelium of domed villi, and especially enterocytes lining 
basolateral villi.  
Finally, in Chapter IV, we investigated the global temporal gene 
expression profiles of BLAD ileal tissues compared to normal calves by 
microarray technology using a custom 13K bovine-specific oligoarray. Analysis of 
microarray data was performed using the suite of gene expression analysis and 
modeling tools developed by Seralogix. Analysis of our data revealed that 
intestinal infection is initially associated with pro-inflammatory gene expression, 
which is positively regulated by the mild influx of neutrophils seen at this early 
stage, yet is independent of Toll-like receptor (TLR) activation. After this initial 
stage, the TLR is activated along with several other pro-inflammatory genes. 
Interestingly, unlike the inflammatory genes, the TLR pathway was consistently 
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activated in BLAD indicating that TLR activation is not under influence of 
neutrophil influx, but instead, is triggered exclusively by bacterial invasion. In 
contrast, expression of inflammatory genes other than TLR-associated genes 
throughout the course of acute infection was highly dependent on the presence 
of neutrophils. Our data also indicated that this activation of inflammatory genes 
and the presence of tissue neutrophils in the initial stages of infection led to 
changes in gene expression the escape escaping of bacteria from innate and 
acquired immune systems, as demonstrated by down-regulation of genes that 
promote leukocyte endothelial transmigration and acquired immunity. Also, these 
data provided evidence that neutrophil influx is required for pro-inflammatory 
cytokine gene expression in the initial stages, whether by directing the 
expression of genes or by inducing their up-regulation in other cell types. 
Although neutrophils represent the vast majority of inflammatory cells during 
Salmonella-induced enteritis, our data indicated that up-regulation of major 
macrophage chemoattractants, which was independent of neutrophil influx. As an 
attempt to better characterize the cause for the tissue damage that occurs during 
the acute infection, we also analyzed the profile of apoptosis and oxidative 
stress-associated genes. Our microarray data on regulated cell death showed 
that S. typhimurium, in the absence of neutrophil influx predominantly induce 
gene changes that favor anti-apoptotic stimuli but the presence of neutrophils 
appeared to trigger apoptosis. Analysis of our data showed that activation of 
oxidative and nitrosative stress in both animal groups were markedly controlled 
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by the up-regulation of antioxidant genes regardless of the presence or absence 
of neutrophil influx.  
In conclusion, the data presented in these in vivo experiments 
indicated that tissue influx of neutrophils that characterizes the enteritis in non-
typhoidal ruminant and human salmonellosis represent significantly more than 
just a morphologic hallmark of the disease. We found that neutrophils greatly 
contribute to tissue damage and diarrhea, help to control bacterial invasion, and 
greatly influence and modulate host gene expression resulting in activation, 
maintenance, and propagation of a pro-inflammatory phenotype. While in vitro 
studies in polarized and non-polarized cells cultures have introduced indisputably 
valuable information on the pathogenesis of non-typhoidal salmonellosis, our 
investigations have clearly demonstrated that a function-based in vivo model 
capable of mounting an adequate neutrophilic response to infection is essential 
to understand the highly complex network of events that culminate in enteritis, 
tissue damage, and diarrhea.  The results of these investigations will enhance 
our knowledge on the intertwined relationship of morphological and molecular 
pathogenesis of this important world wide enteric disease and most importantly 
provide information that can be used to reveal potential gene targets for novel 
therapeutic approaches. 
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